<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2025//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_250101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">41032173</PMID><DateRevised><Year>2025</Year><Month>10</Month><Day>01</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1435-4373</ISSN><JournalIssue CitedMedium="Internet"><PubDate><Year>2025</Year><Month>Oct</Month><Day>01</Day></PubDate></JournalIssue><Title>European journal of clinical microbiology &amp; infectious diseases : official publication of the European Society of Clinical Microbiology</Title><ISOAbbreviation>Eur J Clin Microbiol Infect Dis</ISOAbbreviation></Journal><ArticleTitle>Community-acquired bacterial meningitis in Southern Sweden 2013-2023: a population-based study of incidence, aetiology and diagnostic yield.</ArticleTitle><ELocationID EIdType="doi" ValidYN="Y">10.1007/s10096-025-05247-w</ELocationID><Abstract><AbstractText Label="PURPOSE" NlmCategory="OBJECTIVE">Despite advances in medical care, bacterial meningitis still poses a considerable health issue from a global perspective. An ageing population and increasing development and use of vaccines are likely to affect the incidence and aetiology. The aim of this study was to describe the incidence and aetiology of community-acquired bacterial meningitis (CABM) in our setting, as well as the serotypes of Streptococcus pneumoniae and Neisseria meningitidis causing CABM, in relation to available vaccines.</AbstractText><AbstractText Label="METHOD" NlmCategory="METHODS">Patients of all ages with CABM in southern Sweden 2013-2023 were included. Patients were identified through records of cerebrospinal fluid tests from the Department of Clinical Microbiology, and through International Classification of Diseases 10 codes for bacterial meningitis. Age-standardised incidence rates were calculated based on the European Standard Population 2013.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">During the study period, 244 episodes of CABM in 238 individuals were identified. Definitive aetiology could be established in 93% of episodes. Mean incidence rate was 1.63 per 100,000 person-years, with a trend of declining incidence during the study period. Streptococcus pneumoniae was the most common pathogen, accounting for 46.7% of episodes. 63.6% of the episodes of pneumococcal meningitis were caused by serotypes included in current vaccines.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Pneumococcal meningitis is the primary driver of incidence and trends of all-cause community-acquired bacterial meningitis in southern Sweden. Further studies are warranted to investigate how vaccination could influence both disease incidence and shifts in serotype distribution, while also identifying optimal patient populations for targeted interventions.</AbstractText><CopyrightInformation>&#xa9; 2025. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>West</LastName><ForeName>Tobias</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Division of Infection Medicine, Department of Clinical Sciences, Faculty of Medicine, Lund University, Lund, Sweden. tobias.west@med.lu.se.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Internal Medicine, Helsingborg hospital, Helsingborg, Sweden. tobias.west@med.lu.se.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Carlander</LastName><ForeName>Robin</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Division of Infection Medicine, Department of Clinical Sciences, Faculty of Medicine, Lund University, Lund, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sunnerhagen</LastName><ForeName>Torgny</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Division of Infection Medicine, Department of Clinical Sciences, Faculty of Medicine, Lund University, Lund, Sweden.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Clinical Microbiology, Infection Control and Prevention, Sk&#xe5;ne University Hospital, Lund, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Torisson</LastName><ForeName>Gustav</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Clinical Infection Medicine, Department of Translational Medicine, Lund University, Malm&#xf6;, Sweden.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Infectious Diseases, Sk&#xe5;ne University Hospital, Malm&#xf6;, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ljungquist</LastName><ForeName>Oskar</ForeName><Initials>O</Initials><AffiliationInfo><Affiliation>Division of Infection Medicine, Department of Clinical Sciences, Faculty of Medicine, Lund University, Lund, Sweden.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Infectious Diseases, Helsingborg hospital, Helsingborg, Sweden.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2025</Year><Month>10</Month><Day>01</Day></ArticleDate></Article><MedlineJournalInfo><Country>Germany</Country><MedlineTA>Eur J Clin Microbiol Infect Dis</MedlineTA><NlmUniqueID>8804297</NlmUniqueID><ISSNLinking>0934-9723</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Aetiology</Keyword><Keyword MajorTopicYN="N">Bacterial meningitis</Keyword><Keyword MajorTopicYN="N">Incidence</Keyword><Keyword MajorTopicYN="N">Serotypes</Keyword><Keyword MajorTopicYN="N">Temporal trend</Keyword><Keyword MajorTopicYN="N">Vaccine-preventable</Keyword></KeywordList><CoiStatement>Declarations. Ethical statement: This study has been approved by the Swedish ethical review authority (reference id 2023-01914-01). Due to the retrospective and observational study design, the need for individual informed consent was waived. All aspects of the study have been conducted in line with the Declaration of Helsinki. Competing interests: The authors have no relevant financial or non-financial interests to disclose.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>10</Month><Day>1</Day><Hour>12</Hour><Minute>31</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>10</Month><Day>1</Day><Hour>12</Hour><Minute>31</Minute></PubMedPubDate><PubMedPubDate PubStatus="received"><Year>2025</Year><Month>6</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2025</Year><Month>8</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>10</Month><Day>1</Day><Hour>11</Hour><Minute>16</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">41032173</ArticleId><ArticleId IdType="doi">10.1007/s10096-025-05247-w</ArticleId><ArticleId IdType="pii">10.1007/s10096-025-05247-w</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>G. B. D. Meningitis antimicrobial resistance collaborators (2023) Global, regional, and National burden of meningitis and its aetiologies, 1990&#x2013;2019: a systematic analysis for the global burden of disease study 2019. Lancet Neurol 22(8):685&#x2013;711</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(23)00195-3</ArticleId></ArticleIdList></Reference><Reference><Citation>van Ettekoven CN, Liechti FD, Brouwer MC, Bijlsma MW, van de Beek D (2024) Global case fatality of bacterial meningitis during an 80-Year period: A systematic review and Meta-Analysis. JAMA Netw Open 7(8):e2424802</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2024.24802</ArticleId><ArticleId IdType="pubmed">39093565</ArticleId><ArticleId IdType="pmc">11297475</ArticleId></ArticleIdList></Reference><Reference><Citation>Edmond K, Clark A, Korczak VS, Sanderson C, Griffiths UK, Rudan I (2010) Global and regional risk of disabling sequelae from bacterial meningitis: a systematic review and meta-analysis. Lancet Infect Dis 10(5):317&#x2013;328</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(10)70048-7</ArticleId><ArticleId IdType="pubmed">20417414</ArticleId></ArticleIdList></Reference><Reference><Citation>World Health Organization. Defeating meningitis by 2030: a global road map [Internet]. Geneva: World Health Organization (2021) [cited 11 November 2024]. Available from: https://www.who.int/initiatives/defeating-meningitis-by-2030</Citation></Reference><Reference><Citation>Brouwer MC, van de Beek D (2018) Epidemiology of community-acquired bacterial meningitis. Curr Opin Infect Dis 31(1):78&#x2013;84</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/QCO.0000000000000417</ArticleId><ArticleId IdType="pubmed">29176349</ArticleId></ArticleIdList></Reference><Reference><Citation>Polkowska A, Toropainen M, Ollgren J, Lyytikainen O, Nuorti JP (2017) Bacterial meningitis in finland, 1995&#x2013;2014: a population-based observational study. BMJ Open 7(5):e015080</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjopen-2016-015080</ArticleId><ArticleId IdType="pubmed">28592578</ArticleId><ArticleId IdType="pmc">5734207</ArticleId></ArticleIdList></Reference><Reference><Citation>Castelblanco RL, Lee M, Hasbun R (2014) Epidemiology of bacterial meningitis in the USA from 1997 to 2010: a population-based observational study. Lancet Infect Dis 14(9):813&#x2013;819</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(14)70805-9</ArticleId><ArticleId IdType="pubmed">25104307</ArticleId></ArticleIdList></Reference><Reference><Citation>Bijlsma MW, Brouwer MC, Kasanmoentalib ES, Kloek AT, Lucas MJ, Tanck MW et al (2016) Community-acquired bacterial meningitis in adults in the netherlands, 2006-14: a prospective cohort study. Lancet Infect Dis 16(3):339&#x2013;347</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(15)00430-2</ArticleId><ArticleId IdType="pubmed">26652862</ArticleId></ArticleIdList></Reference><Reference><Citation>van de Beek D, Brouwer MC, Koedel U, Wall EC (2021) Community-acquired bacterial meningitis. Lancet 398(10306):1171&#x2013;1183</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(21)00883-7</ArticleId><ArticleId IdType="pubmed">34303412</ArticleId></ArticleIdList></Reference><Reference><Citation>McIntyre PB, O&#x2019;Brien KL, Greenwood B, van de Beek D (2012) Effect of vaccines on bacterial meningitis worldwide. Lancet 380(9854):1703&#x2013;1711</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(12)61187-8</ArticleId><ArticleId IdType="pubmed">23141619</ArticleId></ArticleIdList></Reference><Reference><Citation>Hsu HE, Shutt KA, Moore MR, Beall BW, Bennett NM, Craig AS et al (2009) Effect of Pneumococcal conjugate vaccine on Pneumococcal meningitis. N Engl J Med 360(3):244&#x2013;256</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa0800836</ArticleId><ArticleId IdType="pubmed">19144940</ArticleId><ArticleId IdType="pmc">4663990</ArticleId></ArticleIdList></Reference><Reference><Citation>Hanquet G, Krizova P, Valentiner-Branth P, Ladhani SN, Nuorti JP, Lepoutre A et al (2019) Effect of childhood Pneumococcal conjugate vaccination on invasive disease in older adults of 10 European countries: implications for adult vaccination. Thorax 74(5):473&#x2013;482</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/thoraxjnl-2018-211767</ArticleId><ArticleId IdType="pubmed">30355641</ArticleId></ArticleIdList></Reference><Reference><Citation>van de Beek D, de Gans J, Spanjaard L, Weisfelt M, Reitsma JB, Vermeulen M (2004) Clinical features and prognostic factors in adults with bacterial meningitis. N Engl J Med 351(18):1849&#x2013;1859</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa040845</ArticleId><ArticleId IdType="pubmed">15509818</ArticleId></ArticleIdList></Reference><Reference><Citation>Block N, Naucler P, Wagner P, Morfeldt E, Henriques-Normark B (2022) Bacterial meningitis: aetiology, risk factors, disease trends and severe sequelae during 50 years in Sweden. J Intern Med 292(2):350&#x2013;364</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/joim.13488</ArticleId><ArticleId IdType="pubmed">35340067</ArticleId><ArticleId IdType="pmc">9544249</ArticleId></ArticleIdList></Reference><Reference><Citation>Sunnerhagen T, Widen J, Handhal S, Ozkaya Sahin G (2024) A retrospective observational study of 1000 consecutive patients tested with the FilmArray(R) meningitis/encephalitis panel: clinical diagnosis at discharge and Microbiological findings. Sci Rep 14(1):4015</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-024-54621-9</ArticleId><ArticleId IdType="pubmed">38369552</ArticleId><ArticleId IdType="pmc">10874959</ArticleId></ArticleIdList></Reference><Reference><Citation>European Commission: Eurostat. Revision of the European Standard Population &#x2013; Report of Eurostat&#x2019;s task force &#x2013; 2013 edition [Internet]. Publications Office (2013) [cited 17 December 2024]. Available from: https://data.europa.eu/doi/10.2785/11470</Citation></Reference><Reference><Citation>van de Beek D, Cabellos C, Dzupova O, Esposito S, Klein M, Kloek AT et al (2016) ESCMID guideline: diagnosis and treatment of acute bacterial meningitis. Clin Microbiol Infect 22(Suppl 3):S37&#x2013;62</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmi.2016.01.007</ArticleId><ArticleId IdType="pubmed">27062097</ArticleId></ArticleIdList></Reference><Reference><Citation>Spanos A, Harrell FE Jr., Durack DT (1989) Differential diagnosis of acute meningitis. An analysis of the predictive value of initial observations. JAMA 262(19):2700&#x2013;2707</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.1989.03430190084036</ArticleId><ArticleId IdType="pubmed">2810603</ArticleId></ArticleIdList></Reference><Reference><Citation>Arevalo CE, Barnes PF, Duda M, Leedom JM (1989) Cerebrospinal fluid cell counts and chemistries in bacterial meningitis. South Med J 82(9):1122&#x2013;1127</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00007611-198909000-00016</ArticleId><ArticleId IdType="pubmed">2772683</ArticleId></ArticleIdList></Reference><Reference><Citation>Brouwer MC, Tunkel AR, van de Beek D (2010) Epidemiology, diagnosis, and antimicrobial treatment of acute bacterial meningitis. Clin Microbiol Rev 23(3):467&#x2013;492</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/CMR.00070-09</ArticleId><ArticleId IdType="pubmed">20610819</ArticleId><ArticleId IdType="pmc">2901656</ArticleId></ArticleIdList></Reference><Reference><Citation>Okike IO, Johnson AP, Henderson KL, Blackburn RM, Muller-Pebody B, Ladhani SN et al (2014) Incidence, etiology, and outcome of bacterial meningitis in infants aged&#x2009;&lt;&#x2009;90 days in the united Kingdom and Republic of ireland: prospective, enhanced, National population-based surveillance. Clin Infect Dis 59(10):e150&#x2013;e157</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciu514</ArticleId><ArticleId IdType="pubmed">24997051</ArticleId></ArticleIdList></Reference><Reference><Citation>Carmi D, Haklai Z, Gordon ES, Shteiman A, Gabbay U (2023) Trends of bacterial meningitis incidence rate over 20 years (2000 to 2019): the Israel experience. Isr Med Assoc J 25(1):27&#x2013;31</Citation><ArticleIdList><ArticleId IdType="pubmed">36718733</ArticleId></ArticleIdList></Reference><Reference><Citation>Ljungquist O, Blomstergren A, Merkel A, Sunnerhagen T, Holm K, Torisson G (2023) Incidence, aetiology and Temporal trend of bloodstream infections in Southern Sweden from 2006 to 2019: a population-based study. Euro Surveill 28(10):2200519</Citation></Reference><Reference><Citation>Talbot TR, Poehling KA, Hartert TV, Arbogast PG, Halasa NB, Edwards KM et al (2005) Seasonality of invasive Pneumococcal disease: Temporal relation to documented influenza and respiratory syncytial viral circulation. Am J Med 118(3):285&#x2013;291</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.amjmed.2004.09.016</ArticleId><ArticleId IdType="pubmed">15745727</ArticleId></ArticleIdList></Reference><Reference><Citation>The Public Health Agency of Sweden Aktuell veckorapport om influensa [Internet]. The Public Health Agency of Sweden; [updated 30 January 2025; cited 05 February 2025]. Available from: https://www.folkhalsomyndigheten.se/folkhalsorapportering-statistik/statistik-a-o/sjukdomsstatistik/influensa-veckorapporter/aktuell-veckorapport-om-influensa/</Citation></Reference><Reference><Citation>Gounder PP, Zulz T, Desai S, Stenz F, Rudolph K, Tsang R et al (2015) Epidemiology of bacterial meningitis in the North American arctic, 2000&#x2013;2010. J Infect 71(2):179&#x2013;187</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jinf.2015.04.001</ArticleId><ArticleId IdType="pubmed">25864638</ArticleId><ArticleId IdType="pmc">4560175</ArticleId></ArticleIdList></Reference><Reference><Citation>The Public Health Agency of Sweden. Barnvaccinationsprogrammet i Sverige 2020 - &#xc5;rsrapport [Internet]. The Public Health Agency of Sweden (2021) [cited 04 February 2025]. Available from: https://www.folkhalsomyndigheten.se/publikationer-och-material/publikationsarkiv/b/barnvaccinationsprogrammet-i-sverige-2020-arsrapport/</Citation></Reference><Reference><Citation>The Public Health Agency of Sweden. Rekommendationer om pneumokockvaccination till riskgrupper [Internet]. The Public Health Agency of Sweden (2024) [cited 04 February 2025]. Available from: https://www.folkhalsomyndigheten.se/publikationer-och-material/publikationsarkiv/r/rekommendationer-om-pneumokockvaccination-/?pub=56914</Citation></Reference><Reference><Citation>Silva-Costa C, Gomes-Silva J, Pinho MD, Friaes A, Ramirez M, Melo-Cristino J (2022) Continued vaccine breakthrough cases of serotype 3 complicated pneumonia in vaccinated children, Portugal (2016&#x2013;2019). Microbiol Spectr 10(4):e0107722</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/spectrum.01077-22</ArticleId><ArticleId IdType="pubmed">35862941</ArticleId></ArticleIdList></Reference><Reference><Citation>Trotter CL, Waight P, Andrews NJ, Slack M, Efstratiou A, George R et al (2010) Epidemiology of invasive Pneumococcal disease in the pre-conjugate vaccine era: England and wales, 1996&#x2013;2006. J Infect 60(3):200&#x2013;208</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jinf.2009.12.008</ArticleId><ArticleId IdType="pubmed">20035785</ArticleId></ArticleIdList></Reference><Reference><Citation>Galanis I, Lindstrand A, Darenberg J, Browall S, Nannapaneni P, Sjostrom K et al (2016) Effects of PCV7 and PCV13 on invasive Pneumococcal disease and carriage in stockholm, Sweden. Eur Respir J 47(4):1208&#x2013;1218</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/13993003.01451-2015</ArticleId><ArticleId IdType="pubmed">26797033</ArticleId><ArticleId IdType="pmc">4819883</ArticleId></ArticleIdList></Reference><Reference><Citation>The Public Health Agency of Sweden Vaccination mot meningokocker [Internet]. The Public Health Agency of Sweden; [updated 21 February 2024; cited 13 December 2024]. Available from: https://www.folkhalsomyndigheten.se/smittskydd-beredskap/vaccinationer/vacciner-som-anvands-i-sverige/meningokocker/</Citation></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">41020364</PMID><DateCompleted><Year>2025</Year><Month>09</Month><Day>29</Day></DateCompleted><DateRevised><Year>2025</Year><Month>09</Month><Day>29</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2164-554X</ISSN><JournalIssue CitedMedium="Internet"><Volume>21</Volume><Issue>1</Issue><PubDate><Year>2025</Year><Month>Dec</Month></PubDate></JournalIssue><Title>Human vaccines &amp; immunotherapeutics</Title><ISOAbbreviation>Hum Vaccin Immunother</ISOAbbreviation></Journal><ArticleTitle>Multidimensional analysis of costs and outcomes in a Colombian cohort of pediatric <i>Streptococcus pneumoniae</i> meningitis cases (2017-2022).</ArticleTitle><Pagination><StartPage>2562738</StartPage><MedlinePgn>2562738</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">2562738</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1080/21645515.2025.2562738</ELocationID><Abstract><AbstractText><i>Streptococcus pneumoniae</i> meningitis poses a significant public health challenge, imposing substantial burdens on healthcare systems. This study analyzed the costs and outcomes of pneumococcal meningitis in a Colombian cohort of children from 2017 to 2022, using correspondence analysis and cost assessment to explore the impact of vaccination. A retrospective cohort study was conducted, analyzing children under 18&#x2009;years diagnosed with pneumococcal meningitis. A total of 55 cases were analyzed in this cohort study, which, while representative of confirmed cases in the country, reflects the rarity of the disease and poses statistical limitations. Direct healthcare costs were calculated in 2023 USD, and data were assessed using cluster and multiple correspondence analyses (MCA) to evaluate relationships between vaccination status, serotypes, clinical outcomes, and costs. The MCA revealed two main dimensions that collectively explained 31.2% of the total variance. Median direct healthcare costs were ~$2,900 (range ~$500-$21,000), with ICU admission as the primary cost driver. PCV13 vaccination correlated with lower overall patient costs and better clinical outcomes. MCA revealed clustering of vaccinated patients with favorable outcomes and reduced costs, while unvaccinated patients aligned with severe outcomes and higher expenses. This study explores the clinical and economic impact of pneumococcal meningitis in pediatric patients, highlighting the potential protective role of PCV13 vaccination. MCA provided an exploratory framework for examining relationships between vaccination status, serotypes, costs, and outcomes.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>David Escobar Franco</LastName><ForeName>Omar Huang</ForeName><Initials>OH</Initials><Identifier Source="ORCID">0000-0002-4939-0850</Identifier><AffiliationInfo><Affiliation>Escuela de Graduados de la Universidad CES, Medell&#xed;n, Colombia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Grupo de investigaci&#xf3;n en Epidemiologia y Bioestad&#xed;stica, Medell&#xed;n, Colombia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Camacho-Moreno</LastName><ForeName>German</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Red Neumocolombia, Bogot&#xe1;, Colombia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Universidad Nacional de Colombia, Bogot&#xe1;, Colombia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>HOMI Fundaci&#xf3;n Hospital pedi&#xe1;trico de la Misericordia, Bogot&#xe1;, Colombia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Hospital Infantil Universitario de San Jose, Bogot&#xe1;, Colombia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lucia Leal</LastName><ForeName>Aura</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Red Neumocolombia, Bogot&#xe1;, Colombia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Universidad Nacional de Colombia, Bogot&#xe1;, Colombia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Grupo para el control de la resistencia bacteriana en Bogot&#xe1;, GREBO, Bogot&#xe1;, Colombia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pati&#xf1;o</LastName><ForeName>Jaime Alberto</ForeName><Initials>JA</Initials><AffiliationInfo><Affiliation>Red Neumocolombia, Bogot&#xe1;, Colombia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centro de Estudios en Infectolog&#xed;a Pedi&#xe1;trica CEIP, Cali, Colombia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Moreno</LastName><ForeName>Vivian Marcela</ForeName><Initials>VM</Initials><AffiliationInfo><Affiliation>Red Neumocolombia, Bogot&#xe1;, Colombia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vasquez-Hoyos</LastName><ForeName>Pablo</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Red Neumocolombia, Bogot&#xe1;, Colombia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Universidad Nacional de Colombia, Bogot&#xe1;, Colombia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Guti&#xe9;rrez-Tobar</LastName><ForeName>Ivan Felipe</ForeName><Initials>IF</Initials><AffiliationInfo><Affiliation>Red Neumocolombia, Bogot&#xe1;, Colombia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Cl&#xed;nica Infantil Colsubsidio, Bogot&#xe1;, Colombia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Beltr&#xe1;n-Higuera</LastName><ForeName>Sandra J</ForeName><Initials>SJ</Initials><AffiliationInfo><Affiliation>Red Neumocolombia, Bogot&#xe1;, Colombia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>&#xc1;lvarez-Olmos</LastName><ForeName>Martha I</ForeName><Initials>MI</Initials><AffiliationInfo><Affiliation>Red Neumocolombia, Bogot&#xe1;, Colombia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Fundaci&#xf3;n Cardioinfantil-Instituto de Cardiolog&#xed;a, Bogot&#xe1;, Colombia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mari&#xf1;o</LastName><ForeName>Ana Cristina</ForeName><Initials>AC</Initials><AffiliationInfo><Affiliation>Red Neumocolombia, Bogot&#xe1;, Colombia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Hospital Militar Central, Bogot&#xe1;, Colombia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Londo&#xf1;o-Ruiz</LastName><ForeName>Juan Pablo</ForeName><Initials>JP</Initials><AffiliationInfo><Affiliation>Red Neumocolombia, Bogot&#xe1;, Colombia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Cl&#xed;nica Infantil Colsubsidio, Bogot&#xe1;, Colombia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Cl&#xed;nica universitaria Colsanitas- Cl&#xed;nica pedi&#xe1;trica, Bogot&#xe1;, Colombia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Barrero Barreto</LastName><ForeName>Esther Rocio</ForeName><Initials>ER</Initials><AffiliationInfo><Affiliation>Red Neumocolombia, Bogot&#xe1;, Colombia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Hospital Universitario Cl&#xed;nica San Rafael, Bogot&#xe1;, Colombia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Unidad de Servicios de Salud Santa Clara, Subred Centro Oriente, Bogot&#xe1;, Colombia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rojas Hern&#xe1;ndez</LastName><ForeName>Juan Pablo</ForeName><Initials>JP</Initials><AffiliationInfo><Affiliation>Red Neumocolombia, Bogot&#xe1;, Colombia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Hospital Universitario del Valle, Cali, Colombia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Universidad Libre Seccional Cali, Cali, Colombia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Espinosa Acu&#xf1;a</LastName><ForeName>Fabio Enrique</ForeName><Initials>FE</Initials><AffiliationInfo><Affiliation>Red Neumocolombia, Bogot&#xe1;, Colombia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Hospital Infantil Universitario de San Jose, Bogot&#xe1;, Colombia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Arango Ferreira</LastName><ForeName>Catalina</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Red Neumocolombia, Bogot&#xe1;, Colombia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Hospital Universitario San Vicente Fundaci&#xf3;n, Medell&#xed;n, Colombia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Suarez</LastName><ForeName>Martha Alexandra</ForeName><Initials>MA</Initials><AffiliationInfo><Affiliation>Red Neumocolombia, Bogot&#xe1;, Colombia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Unidad de Servicio de Salud Tunal, Bogot&#xe1;, Colombia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Hospital Universitario San Ignacio, Bogot&#xe1;, Colombia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Trujillo Honeysberg</LastName><ForeName>M&#xf3;nica Rosa</ForeName><Initials>MR</Initials><AffiliationInfo><Affiliation>Red Neumocolombia, Bogot&#xe1;, Colombia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Hospital Pablo Tob&#xf3;n Uribe, Medell&#xed;n, Colombia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>L&#xf3;pez Medina</LastName><ForeName>Eduardo</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Red Neumocolombia, Bogot&#xe1;, Colombia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centro de Estudios en Infectolog&#xed;a Pedi&#xe1;trica CEIP, Cali, Colombia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Hospital Universitario del Valle, Cali, Colombia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Cl&#xed;nica Imbanaco Grupo Quironsalud, Cali, Colombia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>L&#xf3;pez</LastName><ForeName>Pio</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Red Neumocolombia, Bogot&#xe1;, Colombia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centro de Estudios en Infectolog&#xed;a Pedi&#xe1;trica CEIP, Cali, Colombia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Hospital Universitario del Valle, Cali, Colombia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Coronell Rodr&#xed;guez</LastName><ForeName>Wilfrido</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Red Neumocolombia, Bogot&#xe1;, Colombia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Hospital Infantil Napole&#xf3;n Franco Pareja, Universidad de Cartagena, Cartagena, Colombia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ramos Rodriguez</LastName><ForeName>Nicolas I</ForeName><Initials>NI</Initials><AffiliationInfo><Affiliation>Red Neumocolombia, Bogot&#xe1;, Colombia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Los COBOS Medical Center, Bogot&#xe1;, Colombia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Restrepo Cede&#xf1;o</LastName><ForeName>Alejandro</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Red Neumocolombia, Bogot&#xe1;, Colombia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Monta&#xf1;ez Ayala</LastName><ForeName>Anita</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Red Neumocolombia, Bogot&#xe1;, Colombia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Giraldo Gallo</LastName><ForeName>Erika</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Escuela de Graduados de la Universidad CES, Medell&#xed;n, Colombia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Grupo de investigaci&#xf3;n en Epidemiologia y Bioestad&#xed;stica, Medell&#xed;n, Colombia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Castro Montoya</LastName><ForeName>Bibiana</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Escuela de Graduados de la Universidad CES, Medell&#xed;n, Colombia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Grupo de investigaci&#xf3;n en Epidemiologia y Bioestad&#xed;stica, Medell&#xed;n, Colombia.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2025</Year><Month>09</Month><Day>29</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Hum Vaccin Immunother</MedlineTA><NlmUniqueID>101572652</NlmUniqueID><ISSNLinking>2164-5515</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D022242">Pneumococcal Vaccines</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C538862">13-valent pneumococcal vaccine</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003105" MajorTopicYN="N" Type="Geographic">Colombia</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008586" MajorTopicYN="Y">Meningitis, Pneumococcal</DescriptorName><QualifierName UI="Q000191" MajorTopicYN="N">economics</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002675" MajorTopicYN="N">Child, Preschool</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D022242" MajorTopicYN="Y">Pneumococcal Vaccines</DescriptorName><QualifierName UI="Q000191" MajorTopicYN="N">economics</QualifierName><QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007223" MajorTopicYN="N">Infant</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013296" MajorTopicYN="N">Streptococcus pneumoniae</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000145" MajorTopicYN="N">classification</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017048" MajorTopicYN="Y">Health Care Costs</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014611" MajorTopicYN="N">Vaccination</DescriptorName><QualifierName UI="Q000191" MajorTopicYN="N">economics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D065288" MajorTopicYN="N">Serogroup</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Pneumococcal meningitis</Keyword><Keyword MajorTopicYN="N">healthcare costs</Keyword><Keyword MajorTopicYN="N">impact</Keyword><Keyword MajorTopicYN="N">multidimensional scaling analysis</Keyword><Keyword MajorTopicYN="N">vaccination</Keyword></KeywordList><CoiStatement>OE is an employee of Pfizer and has not received any financial compensation for conducting this study. GC-M has received support from Pfizer, MSD and Sanofi Pasteur for congresses and conferences, has participated in advisory boards and has received research support from MSD. AL has received support from Pfizer and MSD for congresses, conferences, advisory boards and research. JP-N has received support from Pfizer for congresses. IG has received support from Pfizer for congresses and paid conferences. SB has received support from Pfizer for congresses. Pfizer has supported M&#xc1;-O in congresses. A-CM has received support from Pfizer to attend congresses. RB has received support from Pfizer and MSD to attend congresses. JR has received support from Pfizer for congresses and paid conferences. FE has received research support from MSD. EL-M has received research grants from MSD, GSK, Sanofi Pasteur, Pfizer, Takeda and Janssen. PL has received support from GSK, Sanofi Pasteur and Takeda. WC has received support from Pfizer, GSK and AstraZeneca to attend conferences. The other authors state that there are no conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>9</Month><Day>29</Day><Hour>13</Hour><Minute>19</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>9</Month><Day>29</Day><Hour>13</Hour><Minute>18</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>9</Month><Day>29</Day><Hour>7</Hour><Minute>12</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2025</Year><Month>9</Month><Day>29</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">41020364</ArticleId><ArticleId IdType="doi">10.1080/21645515.2025.2562738</ArticleId><ArticleId IdType="pmc">PMC12482424</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Guerrero MP, Romero AF, Luengas M, D&#xe1;valos DM, Mesa-Monsalve JG, Vivas-Trochez R, Camacho-Moreno G, Trujillo-Valencia M, Giraldo JPC, Mej&#xed;a LF, et al. Etiology and risk factors for admission to the pediatric intensive care unit in children with encephalitis in a developing country. Pediatr Infect Dis J. 2022;41(10):806&#x2013;14. doi: 10.1097/INF.0000000000003637.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/INF.0000000000003637</ArticleId><ArticleId IdType="pubmed">35830514</ArticleId></ArticleIdList></Reference><Reference><Citation>Casta&#xf1;eda-Orjuela C, Alvis-Guzm&#xe1;n N, de la Hoz-Restrepo F.. Impacto de la enfermedad por Streptococcus pneumoniae en poblaci&#xf3;n adulta mayor en Bogot&#xe1;, Colombia, 2008. Rev Salud P&#xfa;blica. 2010;12(1):38&#x2013;50. doi: 10.1590/S0124-00642010000100004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1590/S0124-00642010000100004</ArticleId><ArticleId IdType="pubmed">20628698</ArticleId></ArticleIdList></Reference><Reference><Citation>Ch&#xe1;vez-Bueno S, McCracken GH. Bacterial meningitis in children. Pediatr Clin North Am. 2005;52(3):795&#x2013;810. doi: 10.1016/j.pcl.2005.02.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pcl.2005.02.011</ArticleId><ArticleId IdType="pubmed">15925663</ArticleId></ArticleIdList></Reference><Reference><Citation>H&#xe9;naff F, Levy C, Cohen R, Picard C, Varon E, Guen CGL, Launay E. Risk factors in children older than 5 years with pneumococcal meningitis. Pediatr Infect Dis J. 2017;36(5):457&#x2013;461. doi: 10.1097/INF.0000000000001470.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/INF.0000000000001470</ArticleId><ArticleId IdType="pubmed">28403047</ArticleId></ArticleIdList></Reference><Reference><Citation>Ceyhan M, Ozsurekci Y, Aykac K, Hacibedel B, Ozbilgili E. Economic burden of pneumococcal infections in children under 5 years of age. Hum Vaccines Immunother. 2018;14(1):106&#x2013;110. doi: 10.1080/21645515.2017.1371378.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21645515.2017.1371378</ArticleId><ArticleId IdType="pmc">PMC5791583</ArticleId><ArticleId IdType="pubmed">28922054</ArticleId></ArticleIdList></Reference><Reference><Citation>Torres-Mart&#xed;nez C, Camacho-Moreno G, Pati&#xf1;o-Ni&#xf1;o J, Coronell W, Leal AL, G&#xe1;mez G. Pneumococcal diseases in Colombia: epidemiological analysis before and during the universal children immunization against Streptococcus pneumoniae in the light of a vaccine change in 2022. Infectio. 2024; 33&#x2013;44. doi: 10.22354/24223794.1165.</Citation><ArticleIdList><ArticleId IdType="doi">10.22354/24223794.1165</ArticleId></ArticleIdList></Reference><Reference><Citation>Camacho-Moreno G, Leal AL, Pati&#xf1;o-Ni&#xf1;o J, Vasquez-Hoyos P, Guti&#xe9;rrez I, Beltr&#xe1;n S, &#xc1;lvarez-Olmos MI, Mari&#xf1;o A-C, Londo&#xf1;o-Ruiz JP, Barrero R, et al. Serotype distribution, clinical characteristics, and antimicrobial resistance of pediatric invasive pneumococcal disease in Colombia during PCV10 mass vaccination (2017&#x2013;2022). Front Med. 2024;11:1380125. doi: 10.3389/fmed.2024.1380125.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2024.1380125</ArticleId><ArticleId IdType="pmc">PMC11150640</ArticleId><ArticleId IdType="pubmed">38841583</ArticleId></ArticleIdList></Reference><Reference><Citation>Bahia L, Toscano CM, Takemoto MLS, Araujo DV. Systematic review of pneumococcal disease costs and productivity loss studies in Latin America and the Caribbean. Vaccine. 2013;31:C33&#x2013;44. doi: 10.1016/j.vaccine.2013.05.030.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vaccine.2013.05.030</ArticleId><ArticleId IdType="pubmed">23777689</ArticleId></ArticleIdList></Reference><Reference><Citation>Casta&#xf1;eda-Orjuela C, Romero M, Arce P, Resch S, Janusz CB, Toscano CM, De la Hoz-Restrepo F. Using standardized tools to improve immunization costing data for program planning: the cost of the Colombian expanded program on immunization. Vaccine. 2013;31:C72&#x2013;9. doi: 10.1016/j.vaccine.2013.05.038.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vaccine.2013.05.038</ArticleId><ArticleId IdType="pubmed">23777695</ArticleId></ArticleIdList></Reference><Reference><Citation>Berical AC, Harris D, Cruz CSD, Possick JD. Pneumococcal vaccination strategies. An update and perspective. Ann Am Thorac Soc. 2016;13(6):933&#x2013;944. doi: 10.1513/AnnalsATS.201511-778FR.</Citation><ArticleIdList><ArticleId IdType="doi">10.1513/AnnalsATS.201511-778FR</ArticleId><ArticleId IdType="pmc">PMC5461988</ArticleId><ArticleId IdType="pubmed">27088424</ArticleId></ArticleIdList></Reference><Reference><Citation>Casta&#xf1;eda-Orjuela C, Alvis-Guzm&#xe1;n N, Paternina &#xc1;J, la Hoz-Restrepo FD. Cost-effectiveness of the introduction of the pneumococcal polysaccharide vaccine in elderly Colombian population. Vaccine. 2011;29(44):7644&#x2013;7650. doi: 10.1016/j.vaccine.2011.08.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vaccine.2011.08.006</ArticleId><ArticleId IdType="pubmed">21854825</ArticleId></ArticleIdList></Reference><Reference><Citation>Costa PS, Santos NC, Cunha P, Cotter J, Sousa N. The use of multiple correspondence analysis to explore associations between categories of qualitative variables in healthy ageing. J Aging Res. 2013;2013:302163. doi: 10.1155/2013/302163.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2013/302163</ArticleId><ArticleId IdType="pmc">PMC3810057</ArticleId><ArticleId IdType="pubmed">24222852</ArticleId></ArticleIdList></Reference><Reference><Citation>Camacho-Moreno G, Duarte C, Garc&#xed;a D, Calder&#xf3;n V, Maldonado LY, Castellar L, Moreno J, Palacios J, Gallego &#xc1;, Castillo O, et al. Sentinel surveillance for bacterial pneumonia and meningitis in children under the age of 5 in a tertiary pediatric hospital in Colombia &#x2013; 2016. Biom&#xe9;dica. 2021. Oct 15. 41(Sp. 2):62&#x2013;75. doi: 10.7705/biomedica.5658.</Citation><ArticleIdList><ArticleId IdType="doi">10.7705/biomedica.5658</ArticleId><ArticleId IdType="pmc">PMC8614369</ArticleId><ArticleId IdType="pubmed">34669279</ArticleId></ArticleIdList></Reference><Reference><Citation>Kebede TT, Svensson M, Addissie A, Trollfors B, Andersson R. Cost-effectiveness of childhood pneumococcal vaccination program in Ethiopia: results from a quasi-experimental evaluation. BMC Public Heal. 2019;19(1):1078. doi: 10.1186/s12889-019-7423-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12889-019-7423-8</ArticleId><ArticleId IdType="pmc">PMC6688319</ArticleId><ArticleId IdType="pubmed">31399030</ArticleId></ArticleIdList></Reference><Reference><Citation>Briles DE, Paton JC, Mukerji R, Swiatlo E, Crain MJ. Pneumococcal vaccines. Microbiol Spectr. 2019;7(6). doi: 10.1128/microbiolspec.gpp3-0028-2018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/microbiolspec.gpp3-0028-2018</ArticleId><ArticleId IdType="pmc">PMC10921951</ArticleId><ArticleId IdType="pubmed">31858954</ArticleId></ArticleIdList></Reference><Reference><Citation>Levy C, Ouldali N, Caeymaex L, Angoulvant F, Varon E, Cohen R. Diversity of serotype replacement after pneumococcal conjugate vaccine implementation in Europe. J Pediatr. 2019;213:252&#x2013;253.e3. doi: 10.1016/j.jpeds.2019.07.057.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jpeds.2019.07.057</ArticleId><ArticleId IdType="pubmed">31561776</ArticleId></ArticleIdList></Reference><Reference><Citation>Weinberger DM, Malley R, Lipsitch M. Serotype replacement in disease after pneumococcal vaccination. Lancet. 2011;378(9807):1962&#x2013;1973. doi: 10.1016/S0140-6736(10)62225-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(10)62225-8</ArticleId><ArticleId IdType="pmc">PMC3256741</ArticleId><ArticleId IdType="pubmed">21492929</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang SS, Johnson KM, Ray GT, Wroe P, Lieu TA, Moore MR, Zell ER, Linder JA, Grijalva CG, Metlay JP, et al. Healthcare utilization and cost of pneumococcal disease in the United States. Vaccine. 2011;29(18):3398&#x2013;3412. doi: 10.1016/j.vaccine.2011.02.088.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vaccine.2011.02.088</ArticleId><ArticleId IdType="pubmed">21397721</ArticleId></ArticleIdList></Reference><Reference><Citation>van Warmerdam J, Campigotto A, Bitnun A, MacDougall G, Kirby-Allen M, Papsin B, McGeer A, Allen U, Morris SK. Invasive pneumococcal disease in high-risk children: a 10-year retrospective study. Pediatr Infect Dis J. 2023;42(1):74&#x2013;81. doi: 10.1097/INF.0000000000003748.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/INF.0000000000003748</ArticleId><ArticleId IdType="pubmed">36450100</ArticleId></ArticleIdList></Reference><Reference><Citation>Izquierdo C, Ciruela P, Hern&#xe1;ndez S, Garc&#xed;a-Garc&#xed;a JJ, Esteva C, Moraga-Llop F, D&#xed;az-Conradi A, Mart&#xed;nez-Osorio J, Sol&#xe9;-Ribalta A, Fern&#xe1;ndez de Sevilla M, et al. Pneumococcal serotypes in children, clinical presentation and antimicrobial susceptibility in the PCV13 era. Epidemiol Infect. 2020. Nov 5. 1&#x2013;37. doi: 10.1017/S0950268820002708.</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/S0950268820002708</ArticleId><ArticleId IdType="pmc">PMC7770381</ArticleId><ArticleId IdType="pubmed">33148361</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu T, Song Y, Done N, Mohanty S, Liu Q, Sarpong EM, Lemus-Wirtz E, Signorovitch J, Weiss T. Economic burden of acute otitis media, pneumonia, and invasive pneumococcal disease in children in the United States after the introduction of 13-valent pneumococcal conjugate vaccines during 2014&#x2013;2018. BMC Heal Serv Res. 2023;23(1):398. doi: 10.1186/s12913-023-09244-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12913-023-09244-7</ArticleId><ArticleId IdType="pmc">PMC10127426</ArticleId><ArticleId IdType="pubmed">37098521</ArticleId></ArticleIdList></Reference><Reference><Citation>von Mollendorf C, Tempia S, von Gottberg A, Meiring S, Quan V, Feldman C, Cloete J, Madhi SA, O&#x2019;Brien KL, Klugman KP, et al. Estimated severe pneumococcal disease cases and deaths before and after pneumococcal conjugate vaccine introduction in children younger than 5 years of age in South Africa. PLOS ONE. 2017;12(7):e0179905. doi: 10.1371/journal.pone.0179905.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0179905</ArticleId><ArticleId IdType="pmc">PMC5495214</ArticleId><ArticleId IdType="pubmed">28671978</ArticleId></ArticleIdList></Reference><Reference><Citation>Lovera D, Arbo A. Risk factors for mortality in Paraguayan children with pneumococcal bacterial meningitis. Trop Med Int Heal. 2005;10(12):1235&#x2013;1241. doi: 10.1111/j.1365-3156.2005.01513.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1365-3156.2005.01513.x</ArticleId><ArticleId IdType="pubmed">16359403</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">41017746</PMID><DateCompleted><Year>2025</Year><Month>09</Month><Day>29</Day></DateCompleted><DateRevised><Year>2025</Year><Month>10</Month><Day>01</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">2149-2042</ISSN><JournalIssue CitedMedium="Print"><Volume>40</Volume><Issue>3</Issue><PubDate><Year>2025</Year><Month>Sep</Month><Day>29</Day></PubDate></JournalIssue><Title>Medeniyet medical journal</Title><ISOAbbreviation>Medeni Med J</ISOAbbreviation></Journal><ArticleTitle>Clinical Impact of Cerebrospinal Fluid Multiplex Polymerase Chain Reaction (PCR) Testing in Children with Suspected Central Nervous System Infection.</ArticleTitle><Pagination><StartPage>128</StartPage><EndPage>135</EndPage><MedlinePgn>128-135</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.4274/MMJ.galenos.2025.43895</ELocationID><Abstract><AbstractText Label="OBJECTIVE" NlmCategory="UNASSIGNED">Central nervous system (CNS) infections remain a significant cause of morbidity and mortality in children. This study aimed to evaluate the impact of cerebrospinal fluid (CSF), multiplex polymerase chain reaction (PCR) panel results on clinical decision-making and patient management in children who underwent lumbar puncture (LP) with a preliminary diagnosis of meningitis/meningoencephalitis.</AbstractText><AbstractText Label="METHODS" NlmCategory="UNASSIGNED">Patients aged 1 month to 18 years who underwent LP for suspected CNS infection in our pediatric emergency or intensive care units between 2018 and 2023, and who had a CSF multiplex PCR meningitis/encephalitis panel performed, were retrospectively evaluated in terms of demographics, clinical presentation, laboratory parameters, and treatments. Patients younger than 1 month or older than 18 years, those who underwent LP for non-infectious indications, and those with ventriculoperitoneal shunts were excluded. Data were analyzed using SPSS version 24.</AbstractText><AbstractText Label="RESULTS" NlmCategory="UNASSIGNED">The median age of the 144 patients was 2.7 (6.7) years, and 93 (64.6%) were male. At least one pathogen was detected by multiplex PCR in 35 patients (24.3%). Of these, 22 had viral agents (enterovirus in 9, HSV-1 in 4, HHV-8 in 2, HHV-7 in 2, VZV in 2, CMV in 2, and HHV-6 in 1), 11 had bacterial agents [<i>Streptococcus pneumoniae (S. pneumoniae)</i> in 7, <i>Neisseria meningitidis</i> in 3, and <i>Haemophilus influenzae type b (Hib) in 1</i>], and 2 had multiple agents (<i>S. pneumoniae</i> + <i>Hib</i> + HHV-6 in one case; enterovirus + HHV-6 in one case). No significant clinical differences were observed between viral and bacterial infections. In 51 patients (35.4%), treatment was modified based on PCR results, most often by discontinuing acyclovir (22.1%), antibiotics (7.6%), or both (3.5%).</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="UNASSIGNED">In approximately one-third of cases, unnecessary antiviral or antibiotic treatments were discontinued based on PCR results, demonstrating the utility of molecular diagnostics in guiding clinical management. Especially in patients who had received antibiotics prior to LP, early pathogen detection via PCR may help reduce treatment costs, complications, and length of hospital stay.</AbstractText><CopyrightInformation>Copyright&#xa9; 2025 The Author. Published by Galenos Publishing House on behalf of Istanbul Medeniyet University Faculty of Medicine.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Goktug</LastName><ForeName>Aytac</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0002-0242-2368</Identifier><AffiliationInfo><Affiliation>Istanbul Medeniyet University Faculty of Medicine, Department of Pediatrics, Division of Pediatric Emergency Medicine, Istanbul, T&#xfc;rkiye.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ak Gundogdu</LastName><ForeName>Idil</ForeName><Initials>I</Initials><Identifier Source="ORCID">0009-0000-8448-6965</Identifier><AffiliationInfo><Affiliation>Istanbul Medeniyet University Faculty of Medicine, Department of Pediatrics, Istanbul, T&#xfc;rkiye.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Duyu</LastName><ForeName>Muhterem</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0001-7892-2927</Identifier><AffiliationInfo><Affiliation>Istanbul Medeniyet University Faculty of Medicine, Department of Pediatrics, Division of Pediatric Intensive Care, Istanbul, T&#xfc;rkiye.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Besli</LastName><ForeName>Esen</ForeName><Initials>E</Initials><Identifier Source="ORCID">0000-0001-6837-5384</Identifier><AffiliationInfo><Affiliation>Istanbul Medeniyet University Faculty of Medicine, Department of Pediatrics, Division of Pediatric Emergency Medicine, Istanbul, T&#xfc;rkiye.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>Turkey</Country><MedlineTA>Medeni Med J</MedlineTA><NlmUniqueID>101676811</NlmUniqueID><ISSNLinking>2149-4606</ISSNLinking></MedlineJournalInfo><OtherAbstract Type="Publisher" Language="tur"><AbstractText Label="AMA&#xc7;" NlmCategory="UNASSIGNED">Merkezi sinir sistemi enfeksiyonlar&#x131; &#xe7;ocuklarda hala &#xf6;nemli mortalite ve morbidite nedenleri aras&#x131;ndad&#x131;r. Bu &#xe7;al&#x131;&#x15f;man&#x131;n amac&#x131;, menenjit/meningoensefalit &#xf6;n tan&#x131;s&#x131; ile lomber ponksiyon (LP) yap&#x131;lm&#x131;&#x15f; olan hastalarda bak&#x131;lan beyin omurilik s&#x131;v&#x131;s&#x131; (BOS) multipleks polimeraz zincir reaksiyonu (PCR) paneli sonu&#xe7;lar&#x131;n&#x131;n hasta y&#xf6;netimi &#xfc;zerine etkisinin de&#x11f;erlendirilmesidir.</AbstractText><AbstractText Label="Y&#xd6;NTEMLER" NlmCategory="UNASSIGNED">2018-2023 y&#x131;llar&#x131; aras&#x131;nda &#xe7;ocuk acil ve &#xe7;ocuk yo&#x11f;un bak&#x131;m servislerimizde santral sinir sistemi enfeksiyonu &#x15f;&#xfc;phesiyle LP yap&#x131;lm&#x131;&#x15f; ve BOS multipleks PCR y&#xf6;ntemiyle menenjit/ensefalit paneli g&#xf6;nderilmi&#x15f; olan 1 ay-18 ya&#x15f; aras&#x131;ndaki hastalar demografik, klinik, laboratuvar ve tedavi y&#xf6;ntemleri a&#xe7;&#x131;s&#x131;ndan retrospektif olarak de&#x11f;erlendirildi. &#xc7;al&#x131;&#x15f;mam&#x131;za &lt;1 ay, &gt;18 ya&#x15f;, enfeksiyonla ilgili olmayan durumlar i&#xe7;in LP yap&#x131;lm&#x131;&#x15f; olan hastalar, Ventrik&#xfc;loperitoneal &#x15f;ant&#x131; olan hastalar dahil edilmedi. Verilerin istatistiksel analizleri i&#xe7;in SPSS 24 program&#x131; kullan&#x131;ld&#x131;.</AbstractText><AbstractText Label="BULGULAR" NlmCategory="UNASSIGNED">&#xc7;al&#x131;&#x15f;maya dahil edilen 144 hastan&#x131;n medyan ya&#x15f;&#x131; 2,7 (6,7) y&#x131;ld&#x131; ve 93&#x2019;&#xfc; (%64,6) erkekti. Toplam 144 hastan&#x131;n 35&#x2019;inde (%24,3) multipleks PCR y&#xf6;ntemiyle patojen saptand&#x131;. Bunlar&#x131;n 22&#x2019; sinde vir&#xfc;s (9 enterovir&#xfc;s, 4 HSV-1, 2 HHV-8, 2 HHV-7, 2 VZV, 2 CMV, 1 HHV-6), 11&#x2019;inde bakteri [7 pn&#xf6;mokok, 3 meningokok, 1 <i>Haemophilus influenzae</i> tip b (Hib)], 2&#x2019; sinde &#xe7;oklu pozitiflik (pn&#xf6;mokok + <i>Hib</i> + HHV-6, enterovir&#xfc;s + HHV-6) vard&#x131;. Bakteri ve viral etken tespit edilen 35 olgu klinik bulgular a&#xe7;&#x131;s&#x131;ndan kar&#x15f;&#x131;la&#x15f;t&#x131;r&#x131;ld&#x131;&#x11f;&#x131;nda olgular aras&#x131;nda klinik a&#xe7;&#x131;dan anlaml&#x131; farkl&#x131;l&#x131;k saptanmad&#x131;. Toplam 144 hastan&#x131;n 51&#x2019;sinde (%35,4) BOS-PCR sonucuna g&#xf6;re tedavi de&#x11f;i&#x15f;ikli&#x11f;i yap&#x131;ld&#x131;. En s&#x131;k yap&#x131;lan tedavi de&#x11f;i&#x15f;iklikleri s&#x131;ras&#x131;yla asiklovir tedavisinin kesilmesi (%22,1), antibiyotik tedavisinin kesilmesi (%7,6), asiklovir ve antibiyotik tedavilerinin kesilmesi (%3,5) idi.</AbstractText><AbstractText Label="SONU&#xc7;LAR" NlmCategory="UNASSIGNED">&#xc7;al&#x131;&#x15f;mam&#x131;zda, BOS-PCR sonu&#xe7;lar&#x131;na g&#xf6;re hastalar&#x131;n yakla&#x15f;&#x131;k &#xfc;&#xe7;te birinde gereksiz antiviral ya da antibiyotik tedaviler kesilmi&#x15f; ve bu DOI: 10.4274/MMJ.galenos.2025.43895 molek&#xfc;ler testin hasta y&#xf6;netimine y&#xf6;n verdi&#x11f;i g&#xf6;sterilmi&#x15f;tir. &#xd6;zellikle LP &#xf6;ncesi antibiyotik tedavisi alm&#x131;&#x15f; hastalarda, k&#xfc;lt&#xfc;rde &#xfc;retilemeyen bakterilerin PCR ile erken tespit edilebilmesi ve HSV d&#x131;&#x15f;&#x131;ndaki selim seyirli viral enfeksiyonlarda gereksiz antimikrobiyal tedavinin sonland&#x131;r&#x131;labilmesi i&#xe7;in al&#x131;nan BOS &#xf6;rneklerinden multipleks PCR paneli &#xe7;al&#x131;&#x15f;&#x131;lmas&#x131; gereksiz tedavi maliyetlerini ve komplikasyonlar&#x131; &#xf6;nleyip, hastane yat&#x131;&#x15f; s&#xfc;relerinin azalmas&#x131;na katk&#x131; sa&#x11f;layabilir.</AbstractText><CopyrightInformation>Copyright&#xa9; 2025 The Author. Published by Galenos Publishing House on behalf of Istanbul Medeniyet University Faculty of Medicine.</CopyrightInformation></OtherAbstract><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Central nervous system infections</Keyword><Keyword MajorTopicYN="N">cerebrospinal fluid</Keyword><Keyword MajorTopicYN="N">polymerase chain reaction (PCR)</Keyword></KeywordList><CoiStatement>Conflict of Interest: The authors have no conflict of interest to declare.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>9</Month><Day>29</Day><Hour>13</Hour><Minute>21</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>9</Month><Day>29</Day><Hour>13</Hour><Minute>20</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>9</Month><Day>29</Day><Hour>6</Hour><Minute>17</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2025</Year><Month>9</Month><Day>29</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">41017746</ArticleId><ArticleId IdType="pmc">PMC12478634</ArticleId><ArticleId IdType="doi">10.4274/MMJ.galenos.2025.43895</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Lee BR, Sasidharan A, Harrison CJ, Selvarangan R. Positive impact of routine testing for enterovirus and parechovirus on length of hospitalization and antimicrobial use among inpatients &#x2264;6 months of age. J Clin Microbiol. 2020;59:e02106&#x2013;20.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7771463</ArticleId><ArticleId IdType="pubmed">33055181</ArticleId></ArticleIdList></Reference><Reference><Citation>Turner PC, Brayley J, Downing HC, Homfray GJ, Doolan G, Paul SP. Screening for enteroviral meningitis in infants and children-Is it useful in clinical practice? J Med Virol. 2019;91(10):1882&#x2013;6. doi: 10.1002/jmv.25512.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.25512</ArticleId><ArticleId IdType="pubmed">31180138</ArticleId></ArticleIdList></Reference><Reference><Citation>Robinson CC, Willis M, Meagher A, Gieseker KE, Rotbart H, Glod&#xe9; MP. Impact of rapid polymerase chain reaction results on management of pediatric patients with enteroviral meningitis. Pediatr Infect Dis J. 2002;21(4):283&#x2013;6. doi: 10.1097/00006454-200204000-00005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00006454-200204000-00005</ArticleId><ArticleId IdType="pubmed">12075757</ArticleId></ArticleIdList></Reference><Reference><Citation>Ramers C, Billman G, Hartin M, Ho S, Sawyer MH. Impact of a diagnostic cerebrospinal fluid enterovirus polymerase chain reaction test on patient management. JAMA. 2000;283(20):2680&#x2013;5. doi: 10.1001/jama.283.20.2680.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.283.20.2680</ArticleId><ArticleId IdType="pubmed">10819951</ArticleId></ArticleIdList></Reference><Reference><Citation>Chakrabarti P, Warren C, Vincent L, Kumar Y. Outcome of routine cerebrospinal fluid screening for enterovirus and human parechovirus infection among infants with sepsis-like illness or meningitis in Cornwall, UK. Eur J Pediatr. 2018;177(10):1523&#x2013;9. doi: 10.1007/s00431-018-3209-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00431-018-3209-8</ArticleId><ArticleId IdType="pubmed">30022279</ArticleId></ArticleIdList></Reference><Reference><Citation>Kliegman RM, St. Geme JW, Blum NJ et al. Nelson Textbook of Pediatrics. 21st ed. Philadelphia, PA: Elsevier; 2021.</Citation></Reference><Reference><Citation>Nigrovic LE, Kuppermann N, Macias CG, et al. Clinical prediction rule for identifying children with cerebrospinal fluid pleocytosis at very low risk of bacterial meningitis. JAMA. 2007;297(1):52&#x2013;60. doi: 10.1001/jama.297.1.52.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.297.1.52</ArticleId><ArticleId IdType="pubmed">17200475</ArticleId></ArticleIdList></Reference><Reference><Citation>Nigrovic LE, Malley R, Kuppermann N. Meta-analysis of bacterial meningitis score validation studies. Arch Dis Child. 2012;97(9):799&#x2013;805. doi: 10.1136/archdischild-2012-301798.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/archdischild-2012-301798</ArticleId><ArticleId IdType="pubmed">22764093</ArticleId></ArticleIdList></Reference><Reference><Citation>Leber AL, Everhart K, Balada-Llasat JM, et al. Multicenter evaluation of BioFire FilmArray meningitis/encephalitis panel for detection of bacteria, viruses, and yeast in cerebrospinal fluid specimens. J Clin Microbiol. 2016;54:2251&#x2013;61.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5005480</ArticleId><ArticleId IdType="pubmed">27335149</ArticleId></ArticleIdList></Reference><Reference><Citation>Pfefferle S, Christner M, Aepfelbacher M, L&#xfc;tgehetmann M, Rohde H. Implementation of the FilmArray ME panel in laboratory routine using a simple sample selection strategy for diagnosis of meningitis and encephalitis. BMC Infect Dis. 2020;20(1):170. doi: 10.1186/s12879-020-4904-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12879-020-4904-4</ArticleId><ArticleId IdType="pmc">PMC7036261</ArticleId><ArticleId IdType="pubmed">32087681</ArticleId></ArticleIdList></Reference><Reference><Citation>L&#xf3;pez N, Cuesta G, Rodr&#xed;guez-Vega S, et al. Multiplex real-time PCR FilmArray performance in the diagnosis of meningoencephalitis: lights and shadows. Infection. 2024;52(1):165&#x2013;72. doi: 10.1007/s15010-023-02076-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s15010-023-02076-x</ArticleId><ArticleId IdType="pmc">PMC10810907</ArticleId><ArticleId IdType="pubmed">37515691</ArticleId></ArticleIdList></Reference><Reference><Citation>Ayhan FY, Apa H, Akaslan Kara A, et al. Rapid diagnosis of central nervous system &#x131;nfections by multiplex PCR assay and the viral etiology in children. Mikrobiyol Bul. 2024;58:461&#x2013;70.</Citation><ArticleIdList><ArticleId IdType="pubmed">39745217</ArticleId></ArticleIdList></Reference><Reference><Citation>Mizuno S, Kusama Y, Otake S, Ito Y, Nozaki M, Kasai M. Epidemiology of pediatric meningitis and encephalitis in Japan: a cross-sectional study. Microbiol Spectr. 2024;12(11):e0119224. doi: 10.1128/spectrum.01192-24.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/spectrum.01192-24</ArticleId><ArticleId IdType="pmc">PMC11537098</ArticleId><ArticleId IdType="pubmed">39365047</ArticleId></ArticleIdList></Reference><Reference><Citation>Bal A, Saz EU, Arslan SY, et al. Evaluation of the diagnostic performance of the BioFire FilmArray Meningitis/Encephalitis Panel in children: a retrospective multicenter study. J Ped Infect Dis. 2022;17:252&#x2013;7.</Citation></Reference><Reference><Citation>Kadambari S, Abdullahi F, Celma C, Ladhani S. Epidemiological trends in viral meningitis in England: prospective national surveillance, 2013-2023. J Infect. 2024;89(3):106223. doi: 10.1016/j.jinf.2024.106223.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jinf.2024.106223</ArticleId><ArticleId IdType="pubmed">38986749</ArticleId></ArticleIdList></Reference><Reference><Citation>Sandoni M, Ciardo L, Tamburini C, et al. Enteroviral infections in the first three months of life. Pathogens. 2022;11(1):60. doi: 10.3390/pathogens11010060.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/pathogens11010060</ArticleId><ArticleId IdType="pmc">PMC8782040</ArticleId><ArticleId IdType="pubmed">35056008</ArticleId></ArticleIdList></Reference><Reference><Citation>Simko JP, Caliendo AM, Hogle K, Versalovic J. Differences in laboratory findings for cerebrospinal fluid specimens obtained from patients with meningitis or encephalitis due to herpes simplex virus (HSV) documented by detection of HSV DNA. Clin Infect Dis. 2002;35(4):414&#x2013;9. doi: 10.1086/341979.</Citation><ArticleIdList><ArticleId IdType="doi">10.1086/341979</ArticleId><ArticleId IdType="pubmed">12145725</ArticleId></ArticleIdList></Reference><Reference><Citation>T&#xf6;r&#xfc;n SH, Kaba &#xd6;, Yakut N, et al. Multicenter prospective surveillance study of viral agents causing meningoencephalitis. Sci Rep. 2021;11:7216.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8010096</ArticleId><ArticleId IdType="pubmed">33785855</ArticleId></ArticleIdList></Reference><Reference><Citation>Ceyhan M, G&#xfc;rler N, Ozsurekci Y, et al. Meningitis caused by Neisseria meningitidis, Hemophilus influenzae type b and Streptococcus pneumoniae during 2005-2012 in Turkey: a multicenter prospective surveillance study. Hum Vaccin Immunother. 2014;10:2706&#x2013;12.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4977434</ArticleId><ArticleId IdType="pubmed">25483487</ArticleId></ArticleIdList></Reference><Reference><Citation>Waldrop G, Zucker J, Boubour A, Radmard S, Green DA, Thakur KT. Clinical significance of positive results of the BioFire cerebrospinal fluid FilmArray meningitis/encephalitis panel at a tertiary medical center in the United States. Arch Pathol Lab Med. 2022;146:194&#x2013;200.</Citation><ArticleIdList><ArticleId IdType="pubmed">34086848</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">41003573</PMID><DateCompleted><Year>2025</Year><Month>09</Month><Day>26</Day></DateCompleted><DateRevised><Year>2025</Year><Month>09</Month><Day>29</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2414-6366</ISSN><JournalIssue CitedMedium="Internet"><Volume>10</Volume><Issue>9</Issue><PubDate><Year>2025</Year><Month>Sep</Month><Day>15</Day></PubDate></JournalIssue><Title>Tropical medicine and infectious disease</Title><ISOAbbreviation>Trop Med Infect Dis</ISOAbbreviation></Journal><ArticleTitle>Asymptomatic Pneumococcal Carriage, Antimicrobial Resistance, and Associated Risk Factors Among Paediatric Healthcare Workers in Benin.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">263</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/tropicalmed10090263</ELocationID><Abstract><AbstractText>Healthcare professionals (HCPs) working in paediatric settings are routinely exposed to respiratory pathogens, increasing their risk of asymptomatic colonisation by meningitis-associated bacteria. This study is the first to assess oropharyngeal and nasopharyngeal carriage of major bacterial meningitis pathogens among paediatric HCPs in Benin, and to identify associated risk factors. A cross-sectional analytical study was conducted in nine hospitals between 1 September 2023 and 30 September 2024. Data collection involved a structured questionnaire and paired oropharyngeal and nasopharyngeal swabs. Culture-based identification and antimicrobial susceptibility testing were performed according to CA-SFM guidelines. By culture method, <i>Streptococcus pneumoniae</i> was the most frequently isolated pathogen, mainly from oropharyngeal samples (47.5%). Most of these strains exhibited multidrug resistance. In nasopharyngeal samples analysed by real-time PCR, detection rates for <i>S. pneumoniae</i> were markedly higher (24.4%) compared to culture (5.0%), highlighting the limited sensitivity of conventional methods in detecting asymptomatic carriage. Pneumococcal colonisation was significantly associated with recent respiratory tract infections, and residence in high-risk areas (<i>p</i> &lt; 0.05). These findings underscore the need for enhanced molecular surveillance, along with strengthened infection control measures and targeted vaccination strategies, to mitigate the risk of horizontal transmission in paediatric wards.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Bello</LastName><ForeName>Chakir Ishola</ForeName><Initials>CI</Initials><Identifier Source="ORCID">0000-0001-9417-2820</Identifier><AffiliationInfo><Affiliation>Laboratory of Biology and Molecular Typing in Microbiology, Faculty of Sciences and Techniques, University of Abomey-Calavi, Cotonou P.O. Box 1604, Benin.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Degbey</LastName><ForeName>Cyriaque Comlan</ForeName><Initials>CC</Initials><Identifier Source="ORCID">0000-0002-6037-0287</Identifier><AffiliationInfo><Affiliation>Department of Environmental Health, Regional Institute of Public Health, University of Abomey-Calavi, Ouidah P.O. Box 384, Benin.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>University Hospital Hygiene Clinic, Hubert Koutoukou Maga National Teaching Hospital (CNHU-HKM), Cotonou P.O. Box 386, Benin.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Denon</LastName><ForeName>Yves Eric</ForeName><Initials>YE</Initials><AffiliationInfo><Affiliation>Diagnostic and Exploratory Department, Ministry of Health of Benin, Cotonou P.O. Box 882, Benin.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Adjanonhoun</LastName><ForeName>Adolphe</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>National Institute of Agricultural Research of Benin (INRAB), Cotonou P.O. Box 884, Benin.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Baba-Moussa</LastName><ForeName>Lamine</ForeName><Initials>L</Initials><Identifier Source="ORCID">0000-0002-8160-5954</Identifier><AffiliationInfo><Affiliation>Laboratory of Biology and Molecular Typing in Microbiology, Faculty of Sciences and Techniques, University of Abomey-Calavi, Cotonou P.O. Box 1604, Benin.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2025</Year><Month>09</Month><Day>15</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Trop Med Infect Dis</MedlineTA><NlmUniqueID>101709042</NlmUniqueID><ISSNLinking>2414-6366</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Streptococcus pneumoniae</Keyword><Keyword MajorTopicYN="N">asymptomatic carriage</Keyword><Keyword MajorTopicYN="N">healthcare professional</Keyword><Keyword MajorTopicYN="N">multidrug resistance</Keyword><Keyword MajorTopicYN="N">nasopharyngeal</Keyword><Keyword MajorTopicYN="N">oropharyngeal</Keyword><Keyword MajorTopicYN="N">paediatric units</Keyword></KeywordList><CoiStatement>The authors declare no conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2025</Year><Month>7</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2025</Year><Month>8</Month><Day>31</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2025</Year><Month>9</Month><Day>4</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>9</Month><Day>26</Day><Hour>12</Hour><Minute>33</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>9</Month><Day>26</Day><Hour>12</Hour><Minute>32</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>9</Month><Day>26</Day><Hour>10</Hour><Minute>33</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2025</Year><Month>9</Month><Day>15</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">41003573</ArticleId><ArticleId IdType="pmc">PMC12474293</ArticleId><ArticleId IdType="doi">10.3390/tropicalmed10090263</ArticleId><ArticleId IdType="pii">tropicalmed10090263</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Koutangni T., Cr&#xe9;pey P., Woringer M., Porgho S., Bicaba B.W., Tall H., Mueller J.E. Compartmental Models for Seasonal Hyperendemic Bacterial Meningitis in the African Meningitis Belt. Epidemiol. Infect. 2019;147:e14. doi: 10.1017/S0950268818002625.</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/S0950268818002625</ArticleId><ArticleId IdType="pmc">PMC6520558</ArticleId><ArticleId IdType="pubmed">30264686</ArticleId></ArticleIdList></Reference><Reference><Citation>Barichello T., Catal&#xe3;o C.H.R., Rohlwink U.K., van der Kuip M., Zaharie D., Solomons R.S., van Toorn R., van Furth M.T., Hasbun R., Iovino F., et al. Bacterial Meningitis in Africa. Front. Neurol. 2023;14:822575. doi: 10.3389/fneur.2023.822575.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2023.822575</ArticleId><ArticleId IdType="pmc">PMC9972001</ArticleId><ArticleId IdType="pubmed">36864913</ArticleId></ArticleIdList></Reference><Reference><Citation>GBD 2016 Causes of Death Collaborators Global, Regional, and National Age&#x2013;Sex Specific Mortality for 264 Causes of Death, 1980&#x2013;2016: A Systematic Analysis for the Global Burden of Disease Study 2016. Lancet. 2017;390:1151&#x2013;1210. doi: 10.1016/S0140-6736(17)32152-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(17)32152-9</ArticleId><ArticleId IdType="pmc">PMC5605883</ArticleId><ArticleId IdType="pubmed">28919116</ArticleId></ArticleIdList></Reference><Reference><Citation>van de Beek D., Cabellos C., Dzupova O., Esposito S., Klein M., Kloek A.T., Lucas M.J., Tanck M.W., van der Ende A., van de Beek D. Community-Acquired Bacterial Meningitis in Adults in the Netherlands, 2006&#x2013;2014: A Prospective Cohort Study. Lancet Infect. Dis. 2016;16:339&#x2013;347. doi: 10.1016/S1473-3099(15)00430-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(15)00430-2</ArticleId><ArticleId IdType="pubmed">26652862</ArticleId></ArticleIdList></Reference><Reference><Citation>Godjedo T.P.M., Paraiso M.N., Agbankpe A.J., Dougnon T.V., Degbey C., Ahoyo A., Baba-Moussa L., Bankole H. Surveillance au cas par cas de la m&#xe9;ningite bact&#xe9;rienne au B&#xe9;nin: Analyse des donn&#xe9;es, 2016 &#xe0; 2018. Rev. &#xc9;pid&#xe9;miol. Sant&#xe9; Publique. 2022;70:S171. doi: 10.1016/j.respe.2022.06.117.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.respe.2022.06.117</ArticleId></ArticleIdList></Reference><Reference><Citation>Ramos-Sevillano E., Moscoso M., Garc&#xed;a P., Garc&#xed;a E., Yuste J. Nasopharyngeal Colonization and Invasive Disease Are Enhanced by the Cell Wall Hydrolases LytB and LytC of Streptococcus pneumoniae. PLoS ONE. 2011;6:e23626. doi: 10.1371/journal.pone.0023626.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0023626</ArticleId><ArticleId IdType="pmc">PMC3160309</ArticleId><ArticleId IdType="pubmed">21886805</ArticleId></ArticleIdList></Reference><Reference><Citation>Mongbo V., B&#xe9;hanzin L., Salami L., Amegan N., Ouendo E. Factors Associated with Acute Respiratory Infections in Children Aged 0&#x2013;5 Years in the Y&#xe9;nawa District of Cotonou (Benin) in 2023. Open J. Epidemiol. 2024;14:331&#x2013;342. doi: 10.4236/ojepi.2024.142023.</Citation><ArticleIdList><ArticleId IdType="doi">10.4236/ojepi.2024.142023</ArticleId></ArticleIdList></Reference><Reference><Citation>Bello C., Degbey C.C., Baba-Moussa L. Observance des Pr&#xe9;cautions Standards en Hygi&#xe8;ne Hospitali&#xe8;re dans les Services de P&#xe9;diatrie au B&#xe9;nin. Rev. B&#xe9;n. Mal. Infect. 2024;3:24&#x2013;30.</Citation></Reference><Reference><Citation>Mueller J.E., Yaro S., Ou&#xe9;draogo M.S., Levina N., Njanpop-Lafourcade B.M., Tall H., Idohou R.S., Sanou O., Kroman S.S., Drabo A., et al. Pneumococci in the African Meningitis Belt: Meningitis Incidence and Carriage Prevalence in Children and Adults. PLoS ONE. 2012;7:e52464. doi: 10.1371/journal.pone.0052464.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0052464</ArticleId><ArticleId IdType="pmc">PMC3527509</ArticleId><ArticleId IdType="pubmed">23285051</ArticleId></ArticleIdList></Reference><Reference><Citation>Satzke C., Turner P., Virolainen-Julkunen A., Adrian P.V., Antonio M., Hare K.M., Henao-Restrepo A.M., Leach A.J., Klugman K.P., Porter B.D., et al. Standard Method for Detecting Upper Respiratory Carriage of Streptococcus pneumoniae: Updated Recommendations from the WHO Pneumococcal Carriage Working Group. Vaccine. 2013;32:165&#x2013;179. doi: 10.1016/j.vaccine.2013.08.062.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vaccine.2013.08.062</ArticleId><ArticleId IdType="pubmed">24331112</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsang R.S.W. A Narrative Review of the Molecular Epidemiology and Laboratory Surveillance of Vaccine Preventable Bacterial Meningitis Agents: Streptococcus pneumoniae, Neisseria meningitidis, Haemophilus influenzae, and Streptococcus agalactiae. Microorganisms. 2021;9:449. doi: 10.3390/microorganisms9020449.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/microorganisms9020449</ArticleId><ArticleId IdType="pmc">PMC7926440</ArticleId><ArticleId IdType="pubmed">33671611</ArticleId></ArticleIdList></Reference><Reference><Citation>Steurer L.M., Hetzmannseder M., Willinger B., Starzengruber P., Mikula-Pratschke C., Kormann-Klement A., Weber M., Berger A., Grill A. Streptococcus pneumoniae Colonization in Health Care Professionals at a Tertiary University Pediatric Hospital. Eur. J. Clin. Microbiol. Infect. Dis. 2022;41:971&#x2013;976. doi: 10.1007/s10096-022-04446-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10096-022-04446-z</ArticleId><ArticleId IdType="pmc">PMC9135860</ArticleId><ArticleId IdType="pubmed">35469365</ArticleId></ArticleIdList></Reference><Reference><Citation>Hosuru Subramanya S., Thapa S., Dwedi S.K., Gokhale S., Sathian B., Nayak N., Bairy I. Streptococcus pneumoniae and Haemophilus Species Colonization in Health Care Workers: The Launch of Invasive Infections? BMC Res. Notes. 2016;9:66. doi: 10.1186/s13104-016-1877-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13104-016-1877-x</ArticleId><ArticleId IdType="pmc">PMC4743163</ArticleId><ArticleId IdType="pubmed">26847639</ArticleId></ArticleIdList></Reference><Reference><Citation>Amritha G., Meenakshi N., Selvabai R.A.P., Shanmugam P., Jayaraman P. A Comparative Profile of Oropharyngeal Colonization of Streptococcus pneumoniae and Haemophilus influenzae among Healthcare Workers in a Tertiary Care Hospital and Non-Healthcare Individuals. J. Prev. Med. Hyg. 2020;61:E379&#x2013;E385. doi: 10.15167/2421-4248/jpmh2020.61.3.1479.</Citation><ArticleIdList><ArticleId IdType="doi">10.15167/2421-4248/jpmh2020.61.3.1479</ArticleId><ArticleId IdType="pmc">PMC7595066</ArticleId><ArticleId IdType="pubmed">33150226</ArticleId></ArticleIdList></Reference><Reference><Citation>Samadpanah M., Gachkar L., Salarian S., Hadavand F. Nasopharyngeal Colonization and Levofloxacin Susceptibility of Streptococcus pneumoniae among Healthcare Workers in a Teaching Hospital in Tehran, Iran. Nov. Biomed. 2020;8:129&#x2013;134. doi: 10.22037/nbm.v1i1.27790.</Citation><ArticleIdList><ArticleId IdType="doi">10.22037/nbm.v1i1.27790</ArticleId></ArticleIdList></Reference><Reference><Citation>Waghela P., Davis R., Campbell M., Datta R., Hislop M.S., Vega N.J., Wurst L., Yolda-Carr D., Couch L., Hernandez M., et al. Detection of Pneumococcal Carriage in Asymptomatic Healthcare Workers. Open Forum Infect. Dis. 2025;12:ofaf008. doi: 10.1093/ofid/ofaf008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ofid/ofaf008</ArticleId><ArticleId IdType="pmc">PMC11800483</ArticleId><ArticleId IdType="pubmed">39917332</ArticleId></ArticleIdList></Reference><Reference><Citation>Altmann T., Zuhairy S., Narayanan M., Athiraman N. Use of Face Masks Reduces the Rate of Neonatal Respiratory Infections. J. Hosp. Infect. 2023;138:94&#x2013;96. doi: 10.1016/j.jhin.2023.04.017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jhin.2023.04.017</ArticleId><ArticleId IdType="pmc">PMC10249745</ArticleId><ArticleId IdType="pubmed">37182646</ArticleId></ArticleIdList></Reference><Reference><Citation>Douedi S., Douedi H.  Precautions, Bloodborne, Contact, and Droplet. StatPearls Publishing; Treasure Island, FL, USA: 2025.  [(accessed on 5 April 2025)].  Available online:  https://www.ncbi.nlm.nih.gov/books/NBK551555/</Citation><ArticleIdList><ArticleId IdType="pubmed">31855382</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">40988032</PMID><DateCompleted><Year>2025</Year><Month>09</Month><Day>23</Day></DateCompleted><DateRevised><Year>2025</Year><Month>09</Month><Day>26</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2051-5960</ISSN><JournalIssue CitedMedium="Internet"><Volume>13</Volume><Issue>1</Issue><PubDate><Year>2025</Year><Month>Sep</Month><Day>23</Day></PubDate></JournalIssue><Title>Acta neuropathologica communications</Title><ISOAbbreviation>Acta Neuropathol Commun</ISOAbbreviation></Journal><ArticleTitle>Pharmacologic depletion of border-associated macrophages worsens disease in a mouse model of meningitis.</ArticleTitle><Pagination><StartPage>191</StartPage><MedlinePgn>191</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">191</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s40478-025-02126-5</ELocationID><Abstract><AbstractText>Pneumococcal infection of the leptomeninges triggers a strong inflammatory response, contributing to tissue damage and adverse outcome in meningitis. While border-associated macrophages (BAM) are thought to initiate immune responses against pathogens, their exact role in pneumococcal meningitis (PM) - especially at later stages - remains unclear. This study examined the impact of BAM depletion on disease progression. Mice received intracisternal injections of clodronate liposomes (CL) to deplete BAM, followed three days later by intracisternal infection with Streptococcus pneumoniae. At 18&#xa0;h post-infection, CL-treated mice exhibited clinical signs similar to controls treated with phosphate-buffered saline liposomes (PBSL). However, CL-treated mice had lower cerebrospinal fluid leukocyte counts, increased expression of brain immune mediators, and elevated plasma levels of neuronal damage (NEFL) and astrocyte activation (S100B) markers. Over a 42-h observation period - during which ceftriaxone therapy was started 18&#xa0;h post-infection - CL-treated mice showed significantly worse outcomes: 9 of 12 reached termination criteria versus 1 of 9 PBSL-treated mice. This correlated with more severe neuropathology, higher bacterial loads, and persistent inflammation. Notably, infection with a pneumolysin-deficient mutant conferred strong protection against disease aggravation caused by macrophage depletion, whereas caspase-1 inhibition - despite its known immunosuppressive effects in experimental PM - did not. These findings underscore a critical immunoregulatory role for BAM in PM, particularly in resolving rather than initiating inflammation. Their absence exacerbates disease severity, mainly due to increased bacterial proliferation and elevated levels of bacterial toxins.</AbstractText><CopyrightInformation>&#xa9; 2025. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Dyckhoff-Shen</LastName><ForeName>Susanne</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Neurology, LMU University Hospital, LMU Munich, Munich, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Masouris</LastName><ForeName>Ilias</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Department of Neurology, LMU University Hospital, LMU Munich, Munich, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pfister</LastName><ForeName>Hans-Walter</ForeName><Initials>HW</Initials><AffiliationInfo><Affiliation>Department of Neurology, LMU University Hospital, LMU Munich, Munich, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>V&#xf6;lk</LastName><ForeName>Stefanie</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Neurology, LMU University Hospital, LMU Munich, Munich, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hammerschmidt</LastName><ForeName>Sven</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Molecular Genetics and Infection Biology, Interfaculty Institute for Genetics and Functional Genomics, University of Greifswald, Greifswald, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Klein</LastName><ForeName>Matthias</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Neurology, LMU University Hospital, LMU Munich, Munich, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Koedel</LastName><ForeName>Uwe</ForeName><Initials>U</Initials><AffiliationInfo><Affiliation>Department of Neurology, LMU University Hospital, LMU Munich, Munich, Germany. uwe.koedel@med.uni-muenchen.de.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neurology, Klinikum Grosshadern of the University of Munich, Marchioninistr. 15, D-81377, Munich, Germany. uwe.koedel@med.uni-muenchen.de.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2025</Year><Month>09</Month><Day>23</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Acta Neuropathol Commun</MedlineTA><NlmUniqueID>101610673</NlmUniqueID><ISSNLinking>2051-5960</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0813BZ6866</RegistryNumber><NameOfSubstance UI="D004002">Clodronic Acid</NameOfSubstance></Chemical><Chemical><RegistryNumber>75J73V1629</RegistryNumber><NameOfSubstance UI="D002443">Ceftriaxone</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D008081">Liposomes</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008264" MajorTopicYN="Y">Macrophages</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008586" MajorTopicYN="Y">Meningitis, Pneumococcal</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004195" MajorTopicYN="N">Disease Models, Animal</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004002" MajorTopicYN="N">Clodronic Acid</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008810" MajorTopicYN="N">Mice, Inbred C57BL</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002443" MajorTopicYN="N">Ceftriaxone</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018450" MajorTopicYN="N">Disease Progression</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008081" MajorTopicYN="N">Liposomes</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013296" MajorTopicYN="N">Streptococcus pneumoniae</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Caspase-1</Keyword><Keyword MajorTopicYN="N">Clodronate liposomes</Keyword><Keyword MajorTopicYN="N">Macrophages</Keyword><Keyword MajorTopicYN="N">Mouse model of pneumococcal meningitis</Keyword><Keyword MajorTopicYN="N">Pneumolysin</Keyword><Keyword MajorTopicYN="N">Streptococcus pneumoniae</Keyword></KeywordList><CoiStatement>Declarations. Ethics approval and consent to participate: This study was conducted in accordance with the recommendations in the Guide for the Care and Use of Laboratory Animals (National Research Council, USA), with the German Animal Protection Act, and the European Directive 2010/63/EU. The study protocol was approved by the Committee on the Ethics of Animal Experiments of the Government of Upper Bavaria (Permit numbers 55.2-1-54-2532.Vet_02-17-220 and &#x2212;&#x2009;23&#x2013;164). Consent for publication: Not applicable. Competing interests: The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2025</Year><Month>5</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2025</Year><Month>9</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>9</Month><Day>24</Day><Hour>0</Hour><Minute>40</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>9</Month><Day>24</Day><Hour>0</Hour><Minute>39</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>9</Month><Day>23</Day><Hour>23</Hour><Minute>33</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2025</Year><Month>9</Month><Day>23</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">40988032</ArticleId><ArticleId IdType="pmc">PMC12455799</ArticleId><ArticleId IdType="doi">10.1186/s40478-025-02126-5</ArticleId><ArticleId IdType="pii">10.1186/s40478-025-02126-5</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Lucas MJ, Brouwer MC, Van de Beek D (2016) Neurological sequelae of bacterial meningitis. J Infect 73:18&#x2013;27. 10.1016/j.jinf.2016.04.009</Citation><ArticleIdList><ArticleId IdType="pubmed">27105658</ArticleId></ArticleIdList></Reference><Reference><Citation>Global regional, and national burden of neurological disorders, 1990&#x2013;2016: a systematic analysis for the Global Burden of Disease Study 2016 (2019) Lancet Neurol 18:459&#x2013;480. 10.1016/S1474-4422(18)30499-X.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6459001</ArticleId><ArticleId IdType="pubmed">30879893</ArticleId></ArticleIdList></Reference><Reference><Citation>Van de Beek D, Brouwer M, Hasbun R, Koedel U, Whitney CG, Wijdicks E (2016) Community-acquired bacterial meningitis. Nat Rev Dis Primers 2:16074. 10.1038/nrdp.2016.74</Citation><ArticleIdList><ArticleId IdType="pubmed">27808261</ArticleId></ArticleIdList></Reference><Reference><Citation>Van de Beek D, Brouwer MC, Koedel U, Wall EC (2021) Community-acquired bacterial meningitis. Lancet 398(10306):1171&#x2013;1183. 10.1016/S0140-6736(21)00883-7</Citation><ArticleIdList><ArticleId IdType="pubmed">34303412</ArticleId></ArticleIdList></Reference><Reference><Citation>van Ettekoven CN, Liechti FD, Brouwer MC, Bijlsma MW, Van de Beek D (2024) Global case fatality of bacterial meningitis during an 80-year period: A systematic review and meta-analysis. JAMA Netw Open 7(8):e2424802. 10.1001/jamanetworkopen.2024.24802</Citation><ArticleIdList><ArticleId IdType="pmc">PMC11297475</ArticleId><ArticleId IdType="pubmed">39093565</ArticleId></ArticleIdList></Reference><Reference><Citation>van Soest TM, Chekrouni N, van Sorge NM, Bijlsma MW, Brouwer MC, Van de Beek D (2023) Epidemiology, clinical features and outcome of adults with meningococcal meningitis: a 15-year prospective nationwide cohort study. Lancet Reg Health Eur 30:100640. 10.1016/j.lanepe.2023.100640</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10173179</ArticleId><ArticleId IdType="pubmed">37181455</ArticleId></ArticleIdList></Reference><Reference><Citation>Koelman DLH, Brouwer MC, Ter HL, Bijlsma MW, Van der Ende A, Van de Beek D (2022) Pneumococcal meningitis in adults: a prospective nationwide cohort study over a 20-year period. Clin Infect Dis 74(4):657&#x2013;667. 10.1093/cid/ciab477</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8886910</ArticleId><ArticleId IdType="pubmed">34036322</ArticleId></ArticleIdList></Reference><Reference><Citation>Weber JR, Tuomanen EI (2007) Cellular damage in bacterial meningitis: an interplay of bacterial and host driven toxicity. J Neuroimmunol 184(1&#x2013;2):45&#x2013;52. 10.1016/j.jneuroim.2006.11.016</Citation><ArticleIdList><ArticleId IdType="pubmed">17210186</ArticleId></ArticleIdList></Reference><Reference><Citation>Dyckhoff-Shen S, Masouris I, Islam H, Hammerschmidt S, Angele B, Marathe V et al (2024) Combining antibiotic with anti-TLR2/TLR13 therapy prevents brain pathology in Pneumococcal meningitis. JCI Insight 9(6):e165737. 10.1172/jci.insight.165737</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10972620</ArticleId><ArticleId IdType="pubmed">38358825</ArticleId></ArticleIdList></Reference><Reference><Citation>Zanluqui NG, McGavern DB (2023) Bacterial meningitis hits an immunosuppressive nerve. Nature 615(7952):396&#x2013;394. 10.1038/d41586-023-00540-0</Citation><ArticleIdList><ArticleId IdType="pmc">PMC11443755</ArticleId><ArticleId IdType="pubmed">36859668</ArticleId></ArticleIdList></Reference><Reference><Citation>Vara-Perez M, Movahedi K (2025) Border-associated macrophages as gatekeepers of brain homeostasis and immunity. Immunity 58(5):1085&#x2013;1100. 10.1016/j.immuni.2025.04.005</Citation><ArticleIdList><ArticleId IdType="pmc">PMC12094687</ArticleId><ArticleId IdType="pubmed">40324381</ArticleId></ArticleIdList></Reference><Reference><Citation>Pinho-Ribeiro FA, Deng L, Neel DV, Erdogan O, Basu H, Yang D et al (2023) Bacteria hijack a meningeal neuroimmune axis to facilitate brain invasion. Nature 615(7952):472&#x2013;481. 10.1038/s41586-023-05753-x</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10593113</ArticleId><ArticleId IdType="pubmed">36859544</ArticleId></ArticleIdList></Reference><Reference><Citation>Polfliet MM, Zwijnenburg PJ, Van Furth AM, van Der P, Dopp EA, Renardel DL et al (2001) Meningeal and perivascular macrophages of the central nervous system play a protective role during bacterial meningitis. J Immunol 167(8):4644&#x2013;4650. 10.4049/jimmunol.167.8.4644</Citation><ArticleIdList><ArticleId IdType="pubmed">11591794</ArticleId></ArticleIdList></Reference><Reference><Citation>Trostdorf F, Bruck W, Schmitz-Salue M, Stuertz K, van Hopkins SJ RN, et al (1999) Reduction of meningeal macrophages does not decrease migration of granulocytes into the CSF and brain parenchyma in experimental Pneumococcal meningitis. J Neuroimmunol 99(2):205&#x2013;210. 10.1016/s0165-5728(99)00121-6</Citation><ArticleIdList><ArticleId IdType="pubmed">10505976</ArticleId></ArticleIdList></Reference><Reference><Citation>Malipiero U, Koedel U, Pfister HW, Leveen P, B&#xfc;rki K, Reith W et al (2006) TGF receptor II gene deletion in leukocytes prevents cerebral vasculitis in bacterial meningitis. Brain 129:2404&#x2013;2415. 10.1093/brain/awl192</Citation><ArticleIdList><ArticleId IdType="pubmed">16891635</ArticleId></ArticleIdList></Reference><Reference><Citation>Woehrl B, Brouwer MC, Murr C, Heckenberg SG, Baas F, Pfister HW et al (2011) Complement component 5 contributes to poor disease outcome in humans and mice with Pneumococcal meningitis. J Clin Invest 121(10):3943&#x2013;3953. 10.1172/JCI57522</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3195471</ArticleId><ArticleId IdType="pubmed">21926466</ArticleId></ArticleIdList></Reference><Reference><Citation>Frosch M, Prinz M (2025) Niche-specific therapeutic targeting of myeloid cells in the central nervous system. Immunity 58(5):1101&#x2013;1119. 10.1016/j.immuni.2025.03.016</Citation><ArticleIdList><ArticleId IdType="pubmed">40324377</ArticleId></ArticleIdList></Reference><Reference><Citation>Koedel U, Winkler F, Angele B, Fontana A, Flavell RA, Pfister HW (2002) Role of caspase-1 in experimental Pneumococcal meningitis: evidence from Pharmacologic caspase Inhibition and caspase-1-deficient mice. Ann Neurol 51:319&#x2013;329. 10.1002/ana.10103</Citation><ArticleIdList><ArticleId IdType="pubmed">11891827</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoegen T, Tremel N, Klein M, Angele B, Wagner H, Kirschning C et al (2011) The NLRP3 inflammasome contributes to brain injury in Pneumococcal meningitis and is activated through ATP-dependent lysosomal cathepsin B release. J Immunol 187(10):5440&#x2013;5451. 10.4049/jimmunol.1100790</Citation><ArticleIdList><ArticleId IdType="pubmed">22003197</ArticleId></ArticleIdList></Reference><Reference><Citation>Geldhoff M, Mook-Kanamori BB, Brouwer MC, Troost D, Leemans JC, Flavell RA et al (2013) Inflammasome activation mediates inflammation and outcome in humans and mice with Pneumococcal meningitis. BMC Infect Dis 13(1):358. 10.1186/1471-2334-13-358</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3750264</ArticleId><ArticleId IdType="pubmed">23902681</ArticleId></ArticleIdList></Reference><Reference><Citation>Generoso JS, Faller CJ, Collodel A, Catalao CHR, Dominguini D, Petronilho F et al (2023) NLRP3 activation contributes to memory impairment in an experimental model of Pneumococcal meningitis. Mol Neurobiol 61(1):239&#x2013;251. 10.1007/s12035-023-03549-8</Citation><ArticleIdList><ArticleId IdType="pmc">PMC11409915</ArticleId><ArticleId IdType="pubmed">37603152</ArticleId></ArticleIdList></Reference><Reference><Citation>Mitchell TJ, Dalziel CE (2014) The biology of Pneumolysin. Subcell Biochem 80:145&#x2013;160. 10.1007/978-94-017-8881-6_8</Citation><ArticleIdList><ArticleId IdType="pubmed">24798011</ArticleId></ArticleIdList></Reference><Reference><Citation>Nishimoto AT, Rosch JW, Tuomanen EI (2020) Pneumolysin: pathogenesis and therapeutic target. Front Microbiol 11:1543. 10.3389/fmicb.2020.01543</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7343714</ArticleId><ArticleId IdType="pubmed">32714314</ArticleId></ArticleIdList></Reference><Reference><Citation>Pereira JM, Xu S, Leong JM, Sousa S (2022) The Yin and Yang of Pneumolysin during Pneumococcal infection. Front Immunol 13:878244. 10.3389/fimmu.2022.878244</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9074694</ArticleId><ArticleId IdType="pubmed">35529870</ArticleId></ArticleIdList></Reference><Reference><Citation>Chow SH, Deo P, Naderer T (2016) Macrophage cell death in microbial infections. Cell Microbiol 18(4):466&#x2013;474. 10.1111/cmi.12573</Citation><ArticleIdList><ArticleId IdType="pubmed">26833712</ArticleId></ArticleIdList></Reference><Reference><Citation>Nayak D, Zinselmeyer BH, Corps KN, McGavern DB (2012) In vivo dynamics of innate immune sentinels in the CNS. Intravital 1(2):95&#x2013;106. 10.4161/intv.22823</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3784260</ArticleId><ArticleId IdType="pubmed">24078900</ArticleId></ArticleIdList></Reference><Reference><Citation>Laaker C, Baenen C, Kovacs KG, Sandor M, Fabry Z (2023) Immune cells as messengers from the CNS to the periphery: the role of the meningeal lymphatic system in immune cell migration from the CNS. Front Immunol 14:1233908. 10.3389/fimmu.2023.1233908</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10471710</ArticleId><ArticleId IdType="pubmed">37662908</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Hove H, De FD, Greter M, Becher B (2025) Central nervous system macrophages in health and disease. Annu Rev Immunol 43(1):589&#x2013;613. 10.1146/annurev-immunol-082423-041334</Citation><ArticleIdList><ArticleId IdType="pubmed">40036702</ArticleId></ArticleIdList></Reference><Reference><Citation>Rua R, Lee JY, Silva AB, Swafford IS, Maric D, Johnson KR et al (2019) Infection drives meningeal engraftment by inflammatory monocytes that impairs CNS immunity. Nat Immunol 20(4):407&#x2013;419. 10.1038/s41590-019-0344-y</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6481670</ArticleId><ArticleId IdType="pubmed">30886419</ArticleId></ArticleIdList></Reference><Reference><Citation>Gres V, Lohrmann F, Fuchs V, Bosch LFP, L&#xf6;sslein A, Neuber J et al (2024) Dynamic role of monocytes and meningeal macrophages in bacterial meningoencephalitis. bioRxiv:2024. 10.1101/2024.02.27.582183</Citation></Reference><Reference><Citation>Jim KK, Engelen-Lee J, van der Sar AM, Bitter W, Brouwer MC, Van der Ende A et al (2016) Infection of zebrafish embryos with live fluorescent <i>Streptococcus pneumoniae</i> as a real-time Pneumococcal meningitis model. J Neuroinflammation 13(1):188. 10.1186/s12974-016-0655-y
</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4992281</ArticleId><ArticleId IdType="pubmed">27542968</ArticleId></ArticleIdList></Reference><Reference><Citation>Tuomanen EI, Saukkonen K, Sande S, Cioffe C, Wright SD (1989) Reduction of inflammation, tissue damage, and mortality in bacterial meningitis in rabbits treated with monoclonal antibodies against adhesion-promoting receptors of leukocytes. J Exp Med 170:959&#x2013;969. 10.1084/jem.170.3.959</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2189454</ArticleId><ArticleId IdType="pubmed">2570120</ArticleId></ArticleIdList></Reference><Reference><Citation>Koedel U, Frankenberg T, Kirschnek S, Obermaier B, Hacker H, Paul R et al (2009) Apoptosis is essential for neutrophil functional shutdown and determines tissue damage in experimental Pneumococcal meningitis. PLoS Pathog 5(5):e1000461. 10.1371/journal.ppat.1000461</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2682662</ArticleId><ArticleId IdType="pubmed">19478887</ArticleId></ArticleIdList></Reference><Reference><Citation>Mundt S, Greter M, Becher B (2022) The CNS mononuclear phagocyte system in health and disease. Neuron 110(21):3497&#x2013;3512. 10.1016/j.neuron.2022.10.005</Citation><ArticleIdList><ArticleId IdType="pubmed">36327896</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Hove H, Martens L, Scheyltjens I, De VK, Pombo Antunes AR, De PS et al (2019) A single-cell atlas of mouse brain macrophages reveals unique transcriptional identities shaped by ontogeny and tissue environment. Nat Neurosci 22(6):1021&#x2013;1035. 10.1038/s41593-019-0393-4</Citation><ArticleIdList><ArticleId IdType="pubmed">31061494</ArticleId></ArticleIdList></Reference><Reference><Citation>Willis CL, Garwood CJ, Ray DE (2007) A size selective vascular barrier in the rat area Postrema formed by perivascular macrophages and the extracellular matrix. Neuroscience 150(2):498&#x2013;509. 10.1016/j.neuroscience.2007.09.023</Citation><ArticleIdList><ArticleId IdType="pubmed">17945430</ArticleId></ArticleIdList></Reference><Reference><Citation>Mendes-Jorge L, Ramos D, Luppo M, Llombart C, Alexandre-Pires G, Nacher V et al (2009) Scavenger function of resident autofluorescent perivascular macrophages and their contribution to the maintenance of the blood-retinal barrier. Invest Ophthalmol Vis Sci 50(12):5997&#x2013;6005. 10.1167/iovs.09-3515</Citation><ArticleIdList><ArticleId IdType="pubmed">19608545</ArticleId></ArticleIdList></Reference><Reference><Citation>Aertker BM, Kumar A, Prabhakara KS, Smith P, Furman NET, Hasen X et al (2019) Pre-injury monocyte/macrophage depletion results in increased blood-brain barrier permeability after traumatic brain injury. J Neurosci Res 97(6):698&#x2013;707. 10.1002/jnr.24395</Citation><ArticleIdList><ArticleId IdType="pubmed">30746753</ArticleId></ArticleIdList></Reference><Reference><Citation>Adachi K, Miyata K, Chida Y, Hirose M, Morisaki Y, Yamanaka K et al (2023) Depletion of perivascular macrophages delays ALS disease progression by ameliorating blood-spinal cord barrier impairment in SOD1(G93A) mice. Front Cell Neurosci 17:1291673. 10.3389/fncel.2023.1291673</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10704128</ArticleId><ArticleId IdType="pubmed">38077951</ArticleId></ArticleIdList></Reference><Reference><Citation>Santisteban MM, Ahn SJ, Lane D, Faraco G, Garcia-Bonilla L, Racchumi G et al (2020) Endothelium-Macrophage crosstalk mediates Blood-Brain barrier dysfunction in hypertension. Hypertension 76(3):795&#x2013;807. 10.1161/HYPERTENSIONAHA.120.15581</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7429290</ArticleId><ArticleId IdType="pubmed">32654560</ArticleId></ArticleIdList></Reference><Reference><Citation>Pedragosa J, Salas-Perdomo A, Gallizioli M, Cugota R, Miro-Mur F, Brianso F et al (2018) CNS-border associated macrophages respond to acute ischemic stroke attracting granulocytes and promoting vascular leakage. Acta Neuropathol Commun 6(1):76. 10.1186/s40478-018-0581-6</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6083589</ArticleId><ArticleId IdType="pubmed">30092836</ArticleId></ArticleIdList></Reference><Reference><Citation>Rubins JB, Duane PG, Charboneau D, Janoff EN (1992) Toxicity of Pneumolysin to pulmonary endothelial cells in vitro. Infect Immun 60(5):1740&#x2013;1746. 10.1128/iai.60.5.1740-1746.1992</Citation><ArticleIdList><ArticleId IdType="pmc">PMC257067</ArticleId><ArticleId IdType="pubmed">1563759</ArticleId></ArticleIdList></Reference><Reference><Citation>Zysk G, Schneider-Wald BK, Hwang JH, Bejo L, Kim KS, Mitchell TJ et al (2001) Pneumolysin is the main inducer of cytotoxicity to brain microvascular endothelial cells caused by <i>Streptococcus pneumoniae</i>. Infect Immun 69:845&#x2013;852. 10.1128/IAI.69.2.845-852.2001
</Citation><ArticleIdList><ArticleId IdType="pmc">PMC97961</ArticleId><ArticleId IdType="pubmed">11159977</ArticleId></ArticleIdList></Reference><Reference><Citation>Bermpohl D, Halle A, Freyer D, Dagand E, Braun JS, Bechmann I et al (2005) Bacterial programmed cell death of cerebral endothelial cells involves dual death pathways. J Clin Invest 115(6):1607&#x2013;1611. 10.1172/JCI23223</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1088015</ArticleId><ArticleId IdType="pubmed">15902310</ArticleId></ArticleIdList></Reference><Reference><Citation>Witzenrath M, Gutbier B, Hocke AC, Schmeck B, Hippenstiel S, Berger K et al (2006) Role of Pneumolysin for the development of acute lung injury in Pneumococcal pneumonia. Crit Care Med 34(7):1947&#x2013;1954. 10.1097/01.CCM.0000220496.48295.A9</Citation><ArticleIdList><ArticleId IdType="pubmed">16715037</ArticleId></ArticleIdList></Reference><Reference><Citation>Lucas R, Yang G, Gorshkov BA, Zemskov EA, Sridhar S, Umapathy NS et al (2012) Protein kinase C-alpha and arginase I mediate pneumolysin-induced pulmonary endothelial hyperpermeability. Am J Respir Cell Mol Biol 47(4):445&#x2013;453. 10.1165/rcmb.2011-0332OC</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3488628</ArticleId><ArticleId IdType="pubmed">22582175</ArticleId></ArticleIdList></Reference><Reference><Citation>Romero MJ, Yue Q, Ahn WM, Hamacher J, Zaidi Y, Haigh S et al (2025) Endothelial ENaC-alpha restrains oxidative stress in lung capillaries in murine Pneumococcal pneumonia-associated acute lung injury. Am J Respir Cell Mol Biol 72(4):429&#x2013;440. 10.1165/rcmb.2023-0440OC</Citation><ArticleIdList><ArticleId IdType="pmc">PMC12005010</ArticleId><ArticleId IdType="pubmed">39405473</ArticleId></ArticleIdList></Reference><Reference><Citation>Too LK, Ball HJ, McGregor IS, Hunt NH (2014) A novel automated test battery reveals enduring behavioural alterations and cognitive impairments in survivors of murine Pneumococcal meningitis. Brain Behav Immun 35:107&#x2013;124. 10.1016/j.bbi.2013.09.007</Citation><ArticleIdList><ArticleId IdType="pubmed">24060586</ArticleId></ArticleIdList></Reference><Reference><Citation>Wellmer A, Zysk G, Gerber J, Kunst T, von Mering M, Bunkowski S et al (2002) Decreased virulence of a pneumolysin-deficient strain of <i>Streptococcus pneumoniae</i> in murine meningitis. Infect Immun 70(11):6504&#x2013;6508. 10.1128/IAI.70.11.6504-6508.2002
</Citation><ArticleIdList><ArticleId IdType="pmc">PMC130334</ArticleId><ArticleId IdType="pubmed">12379738</ArticleId></ArticleIdList></Reference><Reference><Citation>Wippel C, Maurer J, Fortsch C, Hupp S, Bohl A, Ma J et al (2013) Bacterial Cytolysin during meningitis disrupts the regulation of glutamate in the brain, leading to synaptic damage. PLoS Pathog 9(6):e1003380. 10.1371/journal.ppat.1003380</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3681734</ArticleId><ArticleId IdType="pubmed">23785278</ArticleId></ArticleIdList></Reference><Reference><Citation>Hirst RA, Gosai B, Rutman A, Guerin CJ, Nicotera P, Andrew PW et al (2008) <i>Streptococcus pneumoniae</i> deficient in Pneumolysin or autolysin has reduced virulence in meningitis. J Infect Dis 197:744&#x2013;751. 10.1086/527322
</Citation><ArticleIdList><ArticleId IdType="pubmed">18260758</ArticleId></ArticleIdList></Reference><Reference><Citation>Izadpanah K, Freyer D, Weber JR, Braun JS (2014) Brain parenchymal TNF-alpha and IL-1beta induction in experimental Pneumococcal meningitis. J Neuroimmunol 276(1&#x2013;2):104&#x2013;111. 10.1016/j.jneuroim.2014.08.625</Citation><ArticleIdList><ArticleId IdType="pubmed">25218213</ArticleId></ArticleIdList></Reference><Reference><Citation>Braun JS, Novak R, Herzog K-H, Bodner SM, Cleveland JL, Tuomanen EI (1999) Neuroprotection by a caspase inhibitor in acute bacterial meningitis. Nat Med 5:298&#x2013;302. 10.1038/6514</Citation><ArticleIdList><ArticleId IdType="pubmed">10086385</ArticleId></ArticleIdList></Reference><Reference><Citation>H&#xe4;ndle P, Dyckhoff-Shen S, Angele B, Gorka O, Pfister H-W, Gross O et al (2021) Macrophage pyroptosis aggravates inflammation and pathology in murine Pneumococcal meningitis. ECCMID Online# 941. https://www.escmid.org/fileadmin/escmid/media/pdf/escmid_global/escmid_global_replays/ECCMID_2021_Final_Programme.pdf</Citation></Reference><Reference><Citation>Wall EC, Gordon SB, Hussain S, Goonetilleke UR, Gritzfeld J, Scarborough M et al (2012) Persistence of Pneumolysin in the cerebrospinal fluid of patients with Pneumococcal meningitis is associated with mortality. Clin Infect Dis 54(5):701&#x2013;705. 10.1093/cid/cir926</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3275762</ArticleId><ArticleId IdType="pubmed">22238165</ArticleId></ArticleIdList></Reference><Reference><Citation>Chekrouni N, van Soest TM, da Cruz Campos AC, Brouwer MC, Van de Beek D (2024) Bacterial load in cerebrospinal fluid predicts unfavourable outcome in Pneumococcal meningitis: a prospective nationwide cohort study. Clin Microbiol Infect 30(6):772&#x2013;778. 10.1016/j.cmi.2024.03.012</Citation><ArticleIdList><ArticleId IdType="pubmed">38479702</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Rooijen N, Sanders A (1994) Liposome mediated depletion of macrophages: mechanism of action, Preparation of liposomes and applications. J Immunol Methods 174(1&#x2013;2):83&#x2013;93. 10.1016/0022-1759(94)90012-4</Citation><ArticleIdList><ArticleId IdType="pubmed">8083541</ArticleId></ArticleIdList></Reference><Reference><Citation>Culemann S, Knab K, Euler M, Wegner A, Garibagaoglu H, Ackermann J et al (2023) Stunning of neutrophils accounts for the anti-inflammatory effects of clodronate liposomes. J Exp Med 220(6):e20220525. 10.1084/jem.20220525</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10067541</ArticleId><ArticleId IdType="pubmed">36976180</ArticleId></ArticleIdList></Reference><Reference><Citation>Goldmann T, Wieghofer P, Jordao MJ, Prutek F, Hagemeyer N, Frenzel K et al (2016) Origin, fate and dynamics of macrophages at central nervous system interfaces. Nat Immunol 17(7):797&#x2013;805. 10.1038/ni.3423</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4968048</ArticleId><ArticleId IdType="pubmed">27135602</ArticleId></ArticleIdList></Reference><Reference><Citation>Mrdjen D, Pavlovic A, Hartmann FJ, Schreiner B, Utz SG, Leung BP et al (2018) High-dimensional single-cell mapping of central nervous system immune cells reveals distinct myeloid subsets in health, aging, and disease. Immunity 48(2):380&#x2013;395. 10.1016/j.immuni.2018.01.011</Citation><ArticleIdList><ArticleId IdType="pubmed">29426702</ArticleId></ArticleIdList></Reference><Reference><Citation>Masuda T, Amann L, Monaco G, Sankowski R, Staszewski O, Krueger M et al (2022) Specification of CNS macrophage subsets occurs postnatally in defined niches. Nature 604(7907):740&#x2013;748. 10.1038/s41586-022-04596-2</Citation><ArticleIdList><ArticleId IdType="pubmed">35444273</ArticleId></ArticleIdList></Reference><Reference><Citation>Bjar N, Hermansson A, Gisselsson-Solen M (2024) How common is otogenic meningitis? A retrospective study in Southern Sweden over 18 years. Infection 52(4):1377&#x2013;1384. 10.1007/s15010-024-02195-z</Citation><ArticleIdList><ArticleId IdType="pmc">PMC11289216</ArticleId><ArticleId IdType="pubmed">38416397</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">40987772</PMID><DateRevised><Year>2025</Year><Month>09</Month><Day>23</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1554-8635</ISSN><JournalIssue CitedMedium="Internet"><PubDate><Year>2025</Year><Month>Sep</Month><Day>23</Day></PubDate></JournalIssue><Title>Autophagy</Title><ISOAbbreviation>Autophagy</ISOAbbreviation></Journal><ArticleTitle>Pneumolysin-dependent and independent non-canonical autophagy processes mediate host defense against pneumococcal infection.</ArticleTitle><Pagination><StartPage>1</StartPage><EndPage>20</EndPage><MedlinePgn>1-20</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1080/15548627.2025.2559728</ELocationID><Abstract><AbstractText><i>Streptococcus pneumoniae</i> is an opportunistic pathogen responsible for life-threatening diseases including pneumonia and meningitis. The host defense against pneumococci relies heavily on macrophages, which can effectively internalize and degrade bacteria. Recent studies have implicated both canonical and non-canonical autophagy-related processes in bacterial clearance, but the precise pathways mediating defense against <i>S. pneumoniae</i> remain unknown. Here, we utilize a well-established zebrafish larval infection model to investigate the role of autophagy in host defense against pneumococci <i>in vivo</i>. Using a transgenic macroautophagy/autophagy reporter line, we found the autophagy marker Map1lc3/Lc3 being recruited to pneumococci-containing vesicles upon bacterial internalization by zebrafish macrophages. The genetic inhibition of core autophagy gene <i>atg5</i> led to loss of the Lc3 associations and their impaired acidification, significantly delaying bacterial clearance. This Lc3 recruitment is partially mediated by LC3-associated phagocytosis (LAP), as knockdown of <i>cyba</i> and <i>rubcn</i> moderately reduced Lc3 association with phagosomes and diminished pneumococcal degradation. Interestingly, we observed no involvement of xenophagy components in <i>S. pneumoniae</i>-infected macrophages, suggesting the activation of another non-canonical autophagy pathway, distinct from LAP, targeting pneumococci-containing phagosomes. Instead, we found that the pneumococcal pore-forming toxin pneumolysin induces ROS-independent CASM pathways, one of which is abolished by knockdown of <i>tecpr1a</i> indicating the involvement of sphingomyelin-Tecpr1-induced LC3 lipidation (STIL). Collectively, our observations shed new light on the host immune response against <i>S. pneumoniae</i>, demonstrating that several distinct non-canonical autophagy pathways mediate bacterial degradation by macrophages and providing potential targets for the development of novel therapies to combat pneumococcal infections.<b>Abbreviations</b>: ATG: autophagy related; BMDM: bone marrow-derived macrophage; CASM: conjugation of ATG8 to single membranes; CFU: colony-forming units; Cyba: cytochrome b-245, alpha polypeptide; DPI: diphenyleneiodonium, GFP: green fluorescent protein; hpf: hours post-fertilization; hpi: hours post-infection; LAP: LC3-associated phagocytosis; Map1lc3/Lc3: microtubule-associated protein 1 light chain 3; MEF: mouse embryonic fibroblast; NADPH: nicotinamide adenine dinucleotide phosphate; Optn: optineurin; PINCA: pore-forming toxin-induced non-canonical autophagy; Ply: pneumolysin; ROS: reactive oxygen species; SLR: sequestosome-like receptors; Sqstm1: sequestosome 1; STIL: sphingomyelin-TECPR1-induced LC3 lipidation; Tecpr1: tectonin beta-propeller repeat containing 1.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Michno</LastName><ForeName>Bartosz J</ForeName><Initials>BJ</Initials><Identifier Source="ORCID">0000-0002-7655-649X</Identifier><AffiliationInfo><Affiliation>Department of Evolutionary Immunology, Institute of Zoology and Biomedical Research, Faculty of Biology, Jagiellonian University, Krakow, Poland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Doctoral School of Exact and Natural Sciences, Jagiellonian University, Krakow, Poland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pooranachandran</LastName><ForeName>Niedharsan</ForeName><Initials>N</Initials><Identifier Source="ORCID">0000-0003-4389-3411</Identifier><AffiliationInfo><Affiliation>Department of Evolutionary Immunology, Institute of Zoology and Biomedical Research, Faculty of Biology, Jagiellonian University, Krakow, Poland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Smith</LastName><ForeName>Tonisha C</ForeName><Initials>TC</Initials><Identifier Source="ORCID">0009-0005-8488-8047</Identifier><AffiliationInfo><Affiliation>School for Biosciences, Florey Institute for Host-Pathogen Interactions, University of Sheffield, Sheffield, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Faught</LastName><ForeName>Erin</ForeName><Initials>E</Initials><Identifier Source="ORCID">0000-0003-1489-8336</Identifier><AffiliationInfo><Affiliation>Institute of Biology Leiden, Leiden University, Leiden, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lipowsk&#xe1;</LastName><ForeName>Sandra</ForeName><Initials>S</Initials><Identifier Source="ORCID">0009-0009-4761-4759</Identifier><AffiliationInfo><Affiliation>Department of Evolutionary Immunology, Institute of Zoology and Biomedical Research, Faculty of Biology, Jagiellonian University, Krakow, Poland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fenton</LastName><ForeName>Andrew K</ForeName><Initials>AK</Initials><Identifier Source="ORCID">0000-0003-4042-4580</Identifier><AffiliationInfo><Affiliation>School for Biosciences, Florey Institute for Host-Pathogen Interactions, University of Sheffield, Sheffield, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Meijer</LastName><ForeName>Annemarie H</ForeName><Initials>AH</Initials><Identifier Source="ORCID">0000-0002-1325-0725</Identifier><AffiliationInfo><Affiliation>Institute of Biology Leiden, Leiden University, Leiden, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Prajsnar</LastName><ForeName>Tomasz K</ForeName><Initials>TK</Initials><Identifier Source="ORCID">0000-0001-6562-8630</Identifier><AffiliationInfo><Affiliation>Department of Evolutionary Immunology, Institute of Zoology and Biomedical Research, Faculty of Biology, Jagiellonian University, Krakow, Poland.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2025</Year><Month>09</Month><Day>23</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Autophagy</MedlineTA><NlmUniqueID>101265188</NlmUniqueID><ISSNLinking>1554-8627</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">LAP</Keyword><Keyword MajorTopicYN="N">STIL</Keyword><Keyword MajorTopicYN="N">Streptococcus</Keyword><Keyword MajorTopicYN="N">macrophage</Keyword><Keyword MajorTopicYN="N">pneumoniae</Keyword><Keyword MajorTopicYN="N">zebrafish</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>9</Month><Day>24</Day><Hour>0</Hour><Minute>39</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>9</Month><Day>24</Day><Hour>0</Hour><Minute>39</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>9</Month><Day>23</Day><Hour>23</Hour><Minute>15</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">40987772</ArticleId><ArticleId IdType="doi">10.1080/15548627.2025.2559728</ArticleId></ArticleIdList></PubmedData></PubmedArticle></PubmedArticleSet>